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P o s t -t r a n s c r ip t io n a l  r e g u l a t io n  o f  Id i  in  
PLURIPOTENCY AND SENESCENCE
Typically, levels of inhibitor of DNA binding 1 (Idi) are high in stem cells and 
decrease upon senescence or differentiation. Defining how Id i expression is 
regulated is critical to understanding what happens at the molecular level as 
cells differentiate during development and age in the adult organism.
It has been proposed that zinc finger E-box binding protein (Zeb)l is a repressor 
of the pluripotency regulator Nanog and that Id i maintains embryonic stem 
(ES) cell pluripotency by inhibiting Zebl expression. However, ablation of Id i  in 
mouse ES cells did not alter Zebl protein levels.
Somatic cells can be reprogrammed to pluripotency. The initiation of 
reprogramming without feeder cells was impaired in IdV^' and IdS''' MEFs. 
However, no difference was observed between WT and Idl'^' in the presence of 
feeder cells.
As MEFs were maintained in vitro and approached senescence, Id i protein, but 
not transcript, decreased. microRNAs are short, non-coding RNAs tha t inhibit 
mRNA expression by binding to the 3’ untranslated region (UTR), resulting in 
either degradation or translational repression of the transcript. The 3’ UTRs of 
mouse Id i — Id4 were cloned into a reporter vector. Reporter transcripts were 
repressed by the Id i 3’ UTR, unlike other family members. A 67 base region of 
the Id i 3’ UTR that was necessary for repression contained a predicted miR-381 
/ miR-539-3p binding site. A single point mutation at this site relieved 
repression by the Id i 3’ UTR in a reporter vector. However, attempts to
Ill
modulate activity of these microRNAs did not alter repression by the Id i 3’ UTR 
in a reporter vector, or Id i protein levels.
The present work has identified a previously unknown regulatory element 
located in a highly conserved region of the 3’ UTR of Id i. Whereas the 
mechanism of regulation is unclear, tools have been generated that will allow 
manipulation of this site in a variety of cell lines.
IV
S t a t e m e n t  o f  O r ig in a l it y
This thesis and the work to which it refers are the results of my own efforts. Any 
ideas, data, images or text resulting from the work of others (whether published 
or unpublished) are fully identified as such within the work and attributed to 
their originator in the text, bibliography or in footnotes. This thesis has not been 
submitted in whole or in part for any other academic degree or professional 
qualification. I agree that the University has the right to submit my work to the 
plagiarism detection service TurnitinUK for originality checks. Whether or not 
drafts have been so-assessed, the University reserves the right to require an 
electronic version of the final document (as submitted) for assessment as above.
VA c k n o w l e d g m e n t s
I would like to thank the many, many people that made the present work 
possible and apologise unreservedly to those whose aid has not been attributed 
specifically below — rest assured I am eternally grateful.
Robert Benezra generously provided me with the opportunity and the freedom to 
carry out research in his lab, allowing and encouraging my development as a 
scientist and an independent thinker. Susanna Hourani also supervised me 
from afar, providing support and maintaining a link to Dear Old Blighty.
The Benezra Lab, which in my mind comprises of both past (Christine, Erik, 
Hyung, Juanma, Liz, Ndina, Simona, Rocio, Zvika) and present (Courtney, Dan, 
Riddhi, Rozie, Ingrid, Paulina, Pascal, Peter, Lindy, Marko, Marta, Miriam, 
Svetlana, Yvette) members, was a nourishing environment, coupled with good 
humour and excellent company. Lindy, Peter and Zvika provided much 
appreciated advice and criticism; Courtney expertly maintained the mice used in 
the present work.
Sloan-Kettering Institute is inhabited by extremely talented people th a t are 
only too willing to give up their time and share their expertise; discussions on 
microRNAs, ES cells, reprogramming and other areas, were fuelled by 
Andrea Ventura, Joana Vidigal, Yoon-Chi Han, Lorenz Studer, Inna Lipchina, 
Levi Beverly, Martin Jechlinger, Arun Unni, Gaspare La Rocca,
Scott Olejniczak, Michael Overholtzer and Eirini Papapetrou. Invaluable advice 
on the design and generation of TALENs came from Lukas (Luke) Dow and
VI
Barbara (Babsi) Hopfgartner. The MSKCC Flow Cytometry Core Facility, 
especially P. Jan  Hendrikx, Jennifer Wilshire and Tomas Baumgartner, 
provided a significant amount of training and informal advice.
To properly express my appreciation to the friends whose company I have 
enjoyed during my time in New York, my home away from home, would require 
a separate volume of at least equal size to the present work -  suffice it to say, I 
considerable myself very fortunate to have met them all.
Alex has been a fountain of support -  her patience and willingness to listen to 
my (often incoherent) ramblings is entirely unrivalled. Finally, I close by 
thanking my parents for their tireless sacrifices that afforded me numerous 
opportunities, all of which allowed me to develop into the person I am today.
VII
Dedicated to Miss Vicki Bateman (1926-2011)
VIII
Ta b l e  o f  C o n t e n t s
S t a t e m e n t  o f  Or ig in a l it y ...........................................................................................................iv
A c k n o w l e d g m e n t s ............................................................................................................................. v
Ta b l e  o f  Co n t e n t s ........................................................................................................................ v i i i
L is t  o f  f ig u r e s .....................................................................................................................................x i
L is t  o f  Ta b l e s ...................................................................................................................................x i i i
L is t  o f  A b b r e v ia t io n s ...................................................................................................................x iv
C h a p te r  i; I n t r o d u c t i o n ................................................................................................................i
1-1 Differentiation theory...............................................................................................2
1-1-1 Nuclear transplantation ...................................................................................... 2
1-1-2 Pluripotent cell fusion ...........................................................................................5
1-1-3 Factors that regulate pluripotency..................................................................... 6
1-1-4 Defined factor reprogramming............................................................................8
1-2 iPS cells.......................................................................................................................9
1-2-1 Mechanisms underlying reprogramming.........................................................11
1-2-2 Epigenetic changes occur during reprogramming..........................................13
1-2-2-1 DNA m éthylation............................................................................................. 15
1-2-2-2 Histone modification........................................................................................15
1-2-3 A revised model for reprogramming................................................................. 16
1-2-4 Applications of iPS cell reprogramming........................................................... 17
1-2-5 Improving iPS cell reprogramming...................................................................19
1-3 The Id family of proteins........................................................................................22
1-3-1 Regulation of the Id  family members............................................................... 27
1-3-2 Id proteins and senescence................................................................................ 29
1-3-3 Id proteins as stem cell regulators....................................................................30
1-3-3-1 Id i in mES cells ............................................................................................... 32
1-4 Hypotheses, aims and objectives of the present w ork.......................................34
Ch a p t e r  2: M a t e r ia l s  a n d  M e t h o d s ...................................................................................... 36
2-1 Genotyping of m ice................................................................................................. 36
2-2 Cell culture............................................................................................................... 37
2-2-1 mES cells............................................................................................................... 39
2-2-2 Derivation of M EFs............................................................................................. 39
IX
2-2-3 Generation of iPS cells........................................................................................40
2-2-3-1 Reprogramming via nucleofection................................................................. 41
2-2-3-2 Reprogramming via lentiviral transduction................................................41
2-2-4 Transfection of synthetic miRNA regulators.................................................. 42
2-3 Cloning..................................................................................................................... 43
2-3-1 Cloning Zeb expression constructs................................................................... 44
2-3-2 Cloning 3’ UTRs into psiCHECK2.................................................................... 44
2-3-3 Cloning 3’ UTRs into Bd.LV.............................................................................. 47
2-3-4 Cloning miRNA sponges into pTripZ............................................................... 47
2-3-5 Cloning of TALENs............................................................................................. 52
2-4 AP stain ing .............................................................................................................. 53
2-5 Quantitative polymerase chain reaction............................................................. 55
2-6 Analysis of protein expression.............................................................................. 56
2-6-1 Stock solutions......................................................................................................56
2-6-2 Cell lysis................................................................................................................ 57
2-6-3 Measuring protein concentration......................................................................57
2-6-4 SDS-PAGE............................................................................................................ 57
2-6-5 Western blotting.................................................................................................. 58
2-7 Flow cytometry..............   59
2-8 Luciferase assays.....................................................................................................60
2-9 Assaying TALEN activity.......................................................................................61
2-10 Data analysis.........................................................................................................61
Chapter 3: Results......................................................................................................62
3-1 Re-evaluating the role of Zebl in Nanog regulation..........................................62
3-2 Is Id i required for the acquisition of pluripotency?...........................................69
3-2-1 Generation of iPS cells by nucleofection..........................................................69
3-2-2 Generation of iPS cells by viral transduction................................................. 76
3-2-3 Id i and Id3 deficiency impairs reprogramming............................................. 76
3-2-4 Rescuing the deficiency in reprogramming observed in IdV^' M EFs...........79
3-3 Measuring expression of Id i and Id3 during reprogramming.........................81
3-3-1 Are Id i or Id3 regulated early in reprogramming?........................................81
3-3-2 Are Id i or Id3 induced at later stages in reprogramming?...........................83
3-4 Post-transcriptional regulation of I d i ................................................................. 93
3-4-1 Changes in Id i expression during senescence................................................ 93
X3-4-2 Proteasomal inhibition in MEF undergoing senescence...............................99
3-5 Role of the Id i 3’ UTR in gene expression regulation.................................... 102
3-5-1 How is the Id i 3’ UTR regulated during senescence?................................. 102
3-5-2 What region of the Id i 3’ UTR is required for repression?.........................107
3-5-3 Does altering specific miRNA activity affect Id i regulation?.................... 110
3-5-4 Mutating the endogenous Id i 3’ UTR.............................................................116
Chapter 4: Discussio n ............................................................................................. 119
4-1 The role of Id i in pluripotency............................................................................ 119
4-1-1 Re-evaluating the regulation of Nanog by I d i .............................................. 119
4-1-2 Id i or Id3 deficiency in MEFs impairs feeder free reprogramming 122
4-2 Disparities between Id i protein and mRNA levels.........................................125
4-2-1 Id expression in cells undergoing reprogramming.......................................125
4-2-2 Id i expression during cellular senescence.....................................................127
4-3 Repression of the Id i 3’ UTR increases during senescence............................128
4-3-1 Identification of a conserved regulatory region in the 3’ UTR................... 129
4-3-2 Modulating miRNA activity............................................................................. 130
4-4 Generating tools to mutate the endogenous Id i 3’ UTR................................ 133
4-5 Conclusions............................................................................................................ 136
References................................................................................................................. 137
Appendix: Plasmid Ma p s ..........................................................................................164
XI
L ist  o f  f ig u r e s
Figure 1-1: Summary of reprogramming m ethods.................................................... 3
Figure 1-2: Changes in marker expression during reprogramming......................12
Figure 1-3: Models for defined factor reprogramming............................................. 14
Figure 1-4: Conservation of Id i — Id4....................................................   23
Figure 1-5: E47-NeuroDl binding to DNA................................................................ 25
Figure 1-6: Id protein levels determine bHLH activity...........................................26
Figure 1-7: Preliminary data on the role of Zebl in mES pluripotency...............33
Figure 2-1: Overview of psiCHECK2..........................................................................45
Figure 2-2: Overview of Bd.LV..........................................................................   48
Figure 2-3: Sponge - miRNA binding..........................................................................50
Figure 2-4: Cloning of sponges.....................................................................................51
Figure 2-5: Assaying TALEN efficiency.....................................................................54
Figure 3-1: Zebl and Zeh2 expression in mES cells................................................ 63
Figure 3-2: Alignment of the N-terminus of mouse Zebl and Zeb2.......................64
Figure 3-3: Analysis of protein expression using Zebl antibody 1.........................66
Figure 3-4: Analysis of protein expression using Zebl antibody I I .......................67
Figure 3-5: Testing a Zeb2 antibody for western blotting.......................................68
Figure 3-6: Nucleofection efficiency of pCAG2LMKOSimO in MEFs................... 71
Figure 3-7: Representative iPS colonies.....................................................................72
Figure 3-8: Morphology of a derived iPS line............................................................ 73
Figure 3-9: AP activity in an iPS line.........................................................................74
Figure 3-10: Expression of Nanog in an iPS line ......................................................75
Figure 3-11: Response oîIdV^' MEFs to nucleofection............................................ 77
Figure 3-12: IdT^' and IdS'^' MEFs reprogram at reduced efficiency.....................78
Figure 3-13: Feeder cells rescue the observed deficiency in IdT^' M EFs..............80
Figure 3-14: Analysis of fluorescent protein expression in M EFs.........................82
Figure 3-15: Id i expression after four factor expression.........................................84
Figure 3-16: Id3 expression after four factor expression.........................................85
Figure 3-17: Sorting cells into different stages of reprogramming........................87
Figure 3-18: Nanog expression increases during reprogramming  .............88
Figure 3-19: Changes in Id i mRNA expression during reprogramming.............. 90
Figure 3-20: Changes in Id3 mRNA expression during reprogramming.............. 91
Figure 3-21: Changes in Id i protein levels during reprogramming......................92
XII
Figure 3-22: Change in morphology as MEFs undergo senescence...................... 94
Figure 3-23: Growth curve of MEFs over the course of six passages................... 95
Figure 3-24: Id i expression as MEFs senesce...........................................................97
Figure 3-25: Id i mRNA levels as MEFs senesce..................................................... 98
Figure 3-26: Optimisation of MG132 pre-treatm ent............................................. 100
Figure 3-27: Proteasomal inhibition in MEFs undergoing senescence.............. 101
Figure 3-28: Repression by the 3’ UTR of Id family m em bers.............................103
Figure 3-29: psiCHECK2 in early and late passage M EFs.................................. 104
Figure 3-30: Repression of the Id i 3’ UTR during senescence.............................106
Figure 3-31: Truncation mutants of the Id i 3’ UTR.............................................. 108
Figure 3-32: Point mutations of the Id i 3’ U T R .................................................... 109
Figure 3-33: Using miRNA mimics to modulate the Id i 3’U TR ..........................I l l
Figure 3-34: Using LNAs to inhibit miRNA activity............................................. 112
Figure 3-35: Expression of turboRFP in MEFs transduced with sponges 114
Figure 3-36: Effect of sponges on Id i expression................................................... 115
Figure 3-37: Measuring efficiency of TALENs........................................................118
Figure 4-1: Conservation of the regulatory region in the Id i 3’ UTR................. 131
Figure 4-2: Assaying HR after TALEN activity......................................................135
Figure A-1: Map of pCAG2LMKOSiO..............................................................164
Figure A-2: Map of pLM-fSV2A.........................................................................165
Figure A-3: Map of pBabe-Flag..........................................................................166
Figure A-4: Map of pBabe-Zebl-Flag................................................................ 167
Figure A-5: Map of pBabe-Zeb2-Flag................................................................ 168
Figure A-6: Map of Bd.LV.................................................................................. 169
XIII
L ist  o f  Ta b l e s
Table 2-1: Primers used for genotyping mice............................................................36
Table 2-2: Primers used for cloning into pBabe-Flag..............................................44
Table 2-3: Primers used for cloning 3’ UTRs into psiCHECK2.............................46
Table 2-4: Primers used for cloning 3' UTRs into Bd.LV...................................... 47
Table 2-5: Oligonucleotides used for cloning sponges into pTripZ.......................49
Table 2-6: Sequences of TALENs................................................................................ 52
Table 2-7: Oligonucleotides used for cloning into reporter vector....................... 53
Table 2-8: Primers used for qPCR.............................................................................. 56
Table 2-9: Composition of separating and stacking gels.........................................58
Table 2-10: Antibodies used for western blotting.................................................... 59
xrv
L ist  o f  A b b r e v ia t io n s
? female mouse
male mouse
ANOVA analysis of variance
AP alkaline phosphatase
bHLH basis helix-loop-helix
BMP bone morphogenetic protein
bp base pair
BSA bovine serum albumin
CpG cytosine-phosphate-guanine
D-MEM Dulbecco's modified Eagle medium
DAPI 4',6-diamidino-2-phenylindole
dH20 deionised water
DMSG dimethyl sulfoxide
dpc days post coitum
DSB double strand break
EC embryonic carcinoma
ES embryonic stem
FBS foetal bovine serum
HLH helix-loop-helix
HR homologous recombination
HRP horseradish peroxidase
Id inhibitor of DNA binding
iPS inducible pluripotent stem
LIF leukaemia inhibitory factor
LNA locked nucleic acids oligonucleotide
MEF mouse embryonic fibroblast
mES mouse embryonic stem
miRNA microRNA
P passage
PBS phosphate buffered saline
PBS-T phosphate buffered saline with 0.05% Tween 20
POU Pit-1, Oct-1/2 and Une-86
XV
pRb retinoblastoma protein
qPCR quantitative polymerase chain reaction
RB retinoblastoma
RBP RNA binding protein
RE restriction endonuclease
RT room temperature
SCNT somatic cell nuclear transfer
SE standard error
SMAD Sma and mothers asainst decaventaolesic
SSEAl stage-specific embryonic antigen 1
UTR untranslated region
WT wild-type
Zeb zinc finger E-box binding homeobox
Ch a pt e r  i:  In t r o d u c t io n
Pluripotency, a property that describes a cell’s ability to generate any cell type 
in an organism, is typically only observed briefly during early embryonic 
development. These pluripotent cells are useful as a scientific tool since they can 
be used to study differentiation in vitro. Furthermore, they can be differentiated 
under defined conditions and thus act as a reservoir for specific adult cells. The 
resultant differentiated cells may be used therapeutically, e.g. for 
transplantation of derived tissues. Alternatively, these somatic cells could be 
used in drug discovery, e.g. for drug screens or toxicity testing. Therefore, much 
effort has gone into defining how these pluripotent cells can be derived and 
maintained in culture.
Mammalian development starts with a cell with even more potential: the 
totipotent zygote, resulting from the fertilisation of an ovum by a spermatozoon. 
This totipotent cell will give rise to all cells in the embryo, as well as the 
extraembryonic tissues. The zygote undergoes a series of rapid cellular cleavage 
events, resulting in the morula, a ball of cells that is of similar size to the zygote. 
The cells of the morula continue to divide and form the blastocyst, a hollow ball 
of cells. The trophoblasts (cells that make up the wall of the blastocyst) will give 
rise to extraembryonic tissues, whereas the inner cell mass (ICM; a single 
cluster of cells within the blastocyst) will largely give rise to the embryo 
(Gilbert, 2000).
The cells of the ICM differentiate during gastrulation into the three germ layers: 
the endoderm, the mesoderm and ectoderm. The endoderm (the innermost layer)
will give rise to tissues of the gut and other organs such as the lung or the liver. 
The mesoderm (the middle layer) gives rise to muscles, connective tissue, as well 
as red blood cells. Finally, the ectoderm (the outer layer) gives rise to neural 
tissues and skin cells (Alberts, 2002). Embryonic development continues, with 
cells progressively differentiating into specific subtypes and losing their ability 
to give rise to cells of other lineages, though the mechanisms underlying 
differentiation are still somewhat unclear.
1-1 Differentiation theory
Historically, two general models for differentiation had been proposed: either 
progressive, irreversible loss of genetic information or selective gene expression 
in differentiating cells by other means. Experiments using somatic cell nuclear 
transfer (SCNT), cell fusion and ectopic expression of genes (Figure 1-1) have 
been used to elucidate these mechanisms and attempt to reverse this typically 
unidirectional process. The importance of these studies was recently illustrated 
with the awarding of the Nobel prize to two scientists who made enormous 
advances: John Gurdon and Shinya Yamanaka (Abbott, 2012).
1-1-1 Nuclear transplantation
During SCNT, an unfertilised, enucleated oocyte receives a nucleus from a donor 
cell (Figure 1-lA). The process was first demonstrated in multicellular 
organisms using enucleated Rana pipiens oocytes and donor nuclei from either 
R. pipiens or Rana catesbeiana blastulae (Briggs & King, 1952).
O ocyte
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: >
Pluripotent Cell
1 > 
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Som atic  Cell
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Figure 1-1: Summary of reprogramming m ethods
Three methods of reprogramming are described in the main text. A: SCNT 
involves the transplantation of a somatic nucleus into an enucleated oocyte to 
generate a pluripotent cell. B: Fusion of a pluripotent and a somatic cell results 
in a tetraploid (4n) pluripotent cell. C: Reprogramming with exogenous factors 
(e.g. Oct4, Sox2, Klf4, Myc) can convert somatic cells to pluripotent cells.
Whereas oocytes with syngeneic donors developed into normal embryos, oocytes 
with R. catesbeiana nuclei developed into blastulae that subsequently arrested, 
replicating R. pipiens X R. catesbeiana crossing experiments (Briggs & King, 
1952). Using this technique, Xenopus laevis intestinal epithelium cell nuclei 
were transplanted into enucleated oocytes, resulting in the generation of cloned 
tadpoles (Gurdon, 1962). Whereas the efficiency was low, it demonstrated that 
nuclei from differentiated cells contain the genetic information required for all 
other somatic cells in a multicellular organism.
The first demonstration of successful nuclear transplantation from 
differentiated mammalian cells was performed in sheep: embryonic stem (ES) 
cells were derived and, following in vitro differentiation, nuclei extracted and 
transplanted into enucleated oocytes resulting in cloned sheep (Campbell et al., 
1996). Cloned sheep were subsequently generated from adult mammary gland 
cells, albeit at efficiencies far lower than nuclei from ES cells (Campbell et al., 
1996; Wilmut et al., 1997). The contrast in efficiency of cloning when using 
nuclear material from adult somatic cells and ES cells led to contention tha t 
successful cloning from adult somatic cells was in fact from rare adult stem cells 
and not from differentiated cells (Liu, 2001; Weissman, 2000).
However, the generation of cloned mice from mouse ES (mES) derived via 
nuclear transplantation from B and T cell lymphocytes demonstrated th a t this 
was not the case: the genomic rearrangements that were present in the 
terminally differentiated lymphocytes were present in all cells of the cloned mice 
(Hochedlinger & Jaenisch, 2002). Similar experiments using donor nuclei from 
GFP labelled olfactory sensory neurons (Eggan et al., 2004) or natural killer
T cells (Inoue et al., 2005) confirmed tha t organisms could be cloned from the 
nuclei of terminally differentiated cells. In addition to nuclear transplantation, 
our understanding of the mechanisms underlying differentiation and 
reprogramming took advantage of advancements in the derivation and culture 
of pluripotent cells, and their fusion with somatic cells.
1-1-2 Pluripotent cell fusion
Pluripotent cells that retain the capacity to differentiate into any cell type can 
be obtained from a range of sources. These include embryonic carcinoma (EC) 
cells, which are derived from teratocarcinomas (tumours tha t initiate in germ 
cells) (Kleinsmith & Pierce, 1964; Stevens & Little, 1954). These cells can be 
cultured and retain their pluripotent status in vitro (Finch & Ephrussi, 1967). 
However, when these cells are introduced into blastocysts, they only contribute 
to chimeric mice at poor efficiency (Brinster, 1974). Presumably, the low 
efficiency is the result of the high frequency of chromosomal abnormalities 
observed in these tumours, as EC cells with a normal karyotype can be used to 
generate chimeric mice at higher efficiencies (Stewart & Mintz, 1981).
Pluripotent ES cells are derived from the inner cell mass (ICM) of murine 
(Evans & Kaufman, 1981; Martin, 1981) and human (Thomson et al., 1998) 
blastocysts. In contrast to EC cells, ES cells readily contribute to chimeric mice 
(Nagy et al., 1990). Furthermore, they can be successfully introduced into 
tetraploid blastocysts during tetraploid complementation: the resultant mice 
derive solely from the diploid ES cells (Nagy et al., 1990).
Finally, unipotent primordial germ cells, which give rise to oocytes and 
spermatocytes, can also be cultured in vitro to produce pluripotent embryonic 
germ cells (Matsui et al., 1992; Resnick et al., 1992).
Fusion of pluripotent cells with somatic cells results in pluripotent tetraploid 
cells (Figure 1-lB), e.g. the fusion of embryonic germ cells with lymphocytes 
(Tada et al., 1997), or the fusion of ES cells with murine lymphocytes (Tada et 
al., 2001) and human fibroblasts (Cowan et al., 2005). Embryonic carcinoma 
cells can also be fused with somatic cells to form pluripotent hybrids (Miller & 
Ruddle, 1976).
These experiments suggested that the pluripotent phenotype is dominant over 
the somatic phenotype, though the mechanism underlying these reprogramming 
events was poorly understood; it was even unclear whether the pluripotent 
nucleus or cytoplasm was required for reprogramming to occur. In fact, fusion of 
ES cell karyoplasts (membrane bound nuclei) with neural stem cells with 
resulted in reprogrammed cells (Do & Scholer, 2004). Furthermore, fusion 
resulted in activation of the Oct4 (typically silenced in somatic cells, see below) 
in neural stem cells, which suggested a role for transcription factors (TF) in 
reprogramming to the pluripotent state.
1-1-3 Factors that regulate pluripotency
A number of studies have illustrated the importance of various TFs in 
maintaining human and mouse ES cell pluripotency, with three core factors 
encoded by Oct4 (officially Pou5fl, also known as OctS), Sox2 and Nanog (Boyer 
et al., 2005; Loh et al., 2006).
Oct4 is a POU (named after its homology with pituitary specific TF Pit-1, 
octamer binding TF Oct-1/2 and Caenorhahditis elegans TF Une-86 (Herr et aL, 
1988)) homeodomain TF tha t is expressed in unfertilised oocytes, the ICM of the 
developing blastocyst, ES and EC cells (Okamoto et aL, 1990; Rosner et aL,
1990; Scholer et aL, 1990). Genetic ablation of Oct4 results in embryonic 
lethality and mES cells derived from Oct4' '^ blastocysts are not pluripotent 
(Nichols et aL, 1998).
Oct4 expression is lost upon differentiation of mES cell, induced either by the 
addition of retinoic acid or withdrawal of leukaemia inhibitory factor (LIF) 
(Okamoto et aL, 1990; Palmieri et aL, 1994). Indeed, Oct4 is not expressed in 
adult tissues, outside of the ovary and the testis (Rosner et aL, 1990; Scholer et 
aL, 1990) and ablation of Oct4 does not interfere with adult stem cell function 
(Lengner et aL, 2007). Taken together, these results suggest tha t Oct4 is a 
critical regulator of embryonic pluripotency.
Sox2 is another TF that is required for the development of embryonic and 
extraembryonic tissues (Avilion et aL, 2003). Sox2 can bind as a heterodimer 
with Oct4 to regulate gene expression (Yuan et aL, 1995). In contrast to Oct4 
expression, which is largely absent in the adult organism, Sox2 is expressed in 
the epithelial tissues of the mature organism. Lineage tracing experiments 
suggest that Sox2'*' cells, which derive from Sox2'  ^embryonic cells, act as stem 
cells in adult epithelial tissues (Arnold et aL, 2011). Furthermore, inducible 
ablation of Sox2'  ^cells in the adult mouse interfered with the maintenance of 
these tissues and resulted in lethality (Arnold et aL, 2011).
8Levels of Oct4 and Sox2 define cell fate during development: modest over­
expression of Oct4 leads towards the mesendoderm (the precursor to the 
endoderm and mesoderm), whereas decreased expression leads towards the 
trophectoderm (Hough et al., 2006; Niwa et al., 2000; Niwa et al., 2005). In 
contrast, Sox2 expression blocks differentiation towards the mesendoderm, 
promoting commitment to the neural ectoderm (Thomson et al., 2011). However, 
germ layer commitment cannot take place when Nanog, which is regulated by 
Sox2 and Oct4, is expressed (Rodda et al., 2005).
Nanog was originally identified as a critical regulator of pluripotency in mouse 
and human ES cells (Chambers et al., 2003; Mitsui et al., 2003). Indeed, 
knockdown of Nanog expression caused mES cells to differentiate (Hough et al., 
2006; Ivanova et al., 2006). A more recent study re-evaluated Nanog’s role as a 
maintainer of mES pluripotency and noted that it was expressed transiently in 
culture (Chambers et al., 2007), presumably allowing cells to retain sensitivity 
to differentiation cues. Taken together, these studies suggested that 
reprogramming to the pluripotent state might be possible with ectopically 
expressed genes.
1-1-4 Defined factor reprogramming
Since these prior studies had highlighted the role of TFs in stem cell regulation, 
an alternative approach to reprogramming somatic cells was the ectopic 
expression of genes associated with ES cells and pluripotency (Figure 1-lC). 
Candidate factors were introduced via retroviral transduction into mouse 
embryonic fibroblasts (MEFs) with a neomycin resistance cassette expressed 
from the FhxolS (also known as FhxlS) locus (Takahashi & Yamanaka, 2006), a
9mES specific marker (Tokuzawa et al., 2003). Initially, 24 factors were chosen, 
either for their role in maintaining pluripotency in embryos and mES cells, or 
long term maintenance of the mES identity (Takahashi & Yamanaka, 2006). 
Introduction of the 24 factors into MEFs resulted in the conversion of the 
somatic cells into ones that resembled mES cells and were antibiotic resistance 
(Takahashi & Yamanaka, 2006).
Of the initial candidates, four transcription factors were sufficient to generate 
antibiotic (G418) resistant cells: Oct4, Sox2, Klf4, c-Myc (Takahashi & 
Yamanaka, 2006). Whereas the cells that survived antibiotic selection resembled 
mES cells and phenocopied their proliferation capacity and teratoma formation, 
these induced pluripotent stem (iPS) cells could not be used to generate chimeric 
mice and both the endogenous Nanog and Oct4 regions remained silenced -  i.e. 
their status was dependent on exogenous factor expression (Takahashi & 
Yamanaka, 2006), suggesting that were not completely reprogrammed.
1-2 iPS cells
It was suggested that more stringent selection might permit generation of iPS 
cells that more closely resembled mES cells, since FbxolB expression is not 
required for pluripotency (Tokuzawa et al., 2003). Indeed, antibiotic selection for 
cells that expressed a resistance cassette from either the endogenous Nanog or 
Oct4 locus resulted in iPS cells with appropriate DNA méthylation (Maherali et 
al., 2007; Wernig et al., 2007), retroviral silencing (Maherali et al., 2007) and 
that could contribute to adult chimeras (Okita et al., 2007; Wernig et al., 2007). 
More recently, iPS cells produced using these four factors have been used to
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generate mice via tetraploid complementation, the gold standard for 
pluripotency (Boland et al., 2009; Kang et al., 2009; Zhao et al., 2009).
Despite these similarities, numerous studies have suggested differences in gene 
expression and DNA méthylation between ES and iPS cells (Chin et al., 2009; 
Doi et al., 2009; Wilson et al., 2009). However, it was unclear as to whether 
these differences were the result of genetic differences caused by lentiviral 
integration during reprogramming, genetic background or incomplete silencing 
of transgenes (Brambrink et al., 2006; Okita et al., 2007).
To address this question, a mouse with drug (doxycycline) inducible expression 
of the four factors from the Collai locus was generated, permitting the 
generation of genetically matched iPS and mES cells (Stadtfeld et al., 2010). In 
contrast to previous reports that used genetically disparate cells, gene 
expression in matched mES and iPS cells were extremely similar, though two 
genes (MegS (also known as Gtl2) and Rian) that are both located in the 
Dlkl-Dio3 locus were improperly silenced in most iPS cells (Stadtfeld et al., 
2010).
iPS cells that appropriately expressed these transcripts contributed to chimeras 
at higher percentages and were better able to generate mice via tetraploid 
complementation (Liu et al., 2010; Stadtfeld et al., 2010; Stadtfeld et al., 2012), 
suggesting that these were completely reprogrammed. Whereas great advances 
have been made in the derivation of iPS cells, the mechanisms which permit the 
conversion of somatic cells to pluripotent cells via the ectopic expression of 
factors is not well understood.
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1-2-1 M echanisms underlying reprogramming
Whereas the process of reprogramming MEFs to iPS cells is poorly 
characterised, it appears to involve the transition through several defined states 
in which cells sequentially gain pluripotent characteristics, while losing somatic 
characteristics (Figure 1-2).
Two changes occur early in reprogramming in the vast majority of MEFs 
expressing the four factors. Firstly, expression of Thy-1, a cell surface marker 
that is expressed by a wide range of differentiated cells and by a high 
percentage of MEFs (Rege & Hagood, 2006), is down-regulated (Stadtfeld et al., 
2008b). Secondly, they gain alkaline phosphatase (AP) activity, which is 
observed at high levels in mES cells (Brambrink et al., 2008).
At the next stage of reprogramming, cells express the surface marker stage- 
specific embryonic antigen 1 (SSEAl), which is typically expressed by mES cells 
(Brambrink et al., 2008; Stadtfeld et al., 2008b). Finally, late in reprogramming, 
the Oct4 and Nanog loci, which are silenced in differentiated cells, undergo 
déméthylation and endogenous expression of these pluripotency regulators 
occurs (Brambrink et al., 2008; Stadtfeld et al., 2008b).
Since the process is particularly inefficient (1 — 2% of cells expressing the four 
factors become reprogrammed), it was suggested that secondary events were 
required, possibly resulting from gene inactivation by retroviral integrations 
(Yamanaka, 2007). However, this is unlikely, since iPS cells do not share 
common integration sites (Varas et al., 2009) and can be generated without 
integration into the genome (Okita et al., 2008; Stadtfeld et al., 2008c).
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Figure 1-2: Changes in marker expression during reprogramming
As MEFs transition to iPS cells, they sequentially gain pluripotent, and lose 
somatic, characteristics. Timing is approximate and will vary stochastically, as well 
as with other cell types, other methods of factor introduction and other medium 
compositions. Based on the findings of Brambrink et al. (2008) and Stadtfeld et al.
(2008bX
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Yamanaka (2009) outlined two models of reprogramming to explain this poor 
efficiency. In the “elite” model (Figure 1-3A), a limited number of cells in the 
starting population are capable of undergoing reprogramming, largely restricted 
to a rare subset of less differentiated cells that persist in the adult tissues.
In contrast, the “stochastic” model (Figure 1-3B) contends tha t whereas most or 
all cells in the starting population are able to undergo reprogramming, they 
must also acquire a number of epigenetic changes that occurs in a stochastic and 
asynchronous manner.
1-2-2 Epigenetic changes occur during reprogramming
It is clear from the work of Gurdon (1962) and others that cellular 
differentiation is not accompanied by genetic loss. However, the cells in a 
multicellular organism can be markedly different, so another mechanism by 
which changes in gene expression are regulated must occur. These include 
reversible and heritable regulatory processes such as DNA méthylation histone 
modification and DNA méthylation, broadly referred to as epigenetic regulation. 
It should be noted that usage of this term has changed considerably since its 
first use (Waddington, 1942), and tha t debate continues over its appropriate 
usage (Riddihough & Zahn, 2010). In the present work, the term epigenetic will 
refer to reversible and heritable genetic regulation by processes such as histone 
modification and DNA méthylation
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Figure 1-3: Models for defined factor reprogramming
A: In the elite model, reprogramming is restricted to predetermined 
(orange/blue) cells. B: In the stochastic model, whereas all cells are capable of 
reprogramming, only a small percentage of cells successfully complete the 
process. C: In a combinatorial model, cells that are more differentiated (higher 
orange levels) must pass more epigenetic barriers than less differentiated cells 
(higher blue levels).
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1-2-2-1 DNA m éthylation
Méthylation of DNA typically occurs at cytosine residues (within a cytosine- 
phosphate-guanine (CpG) dinucleotide), resulting in 5 - me thylcy t o sine. CpG 
islands (clusters of CpG sites) are often found in the promoter region of 
mammalian genes. Méthylation of these islands results in gene repression, 
whereas the unmethylated state is observed for housekeeping genes and genes 
that are actively transcribed (Goll & Bestor, 2005).
This modification is heritable (Stein et al., 1982), and the mammalian 
methyltransferase encoded by D nm tl (Bestor et al., 1988) methylates 
hemimethylated DNA (the result of DNA replication) at levels far higher than 
unmethylated DNA (Bestor, 1992). Ablation oî D nm tl in mES cells did not alter 
pluripotency in vitro, but resulted in embryonic lethality (Li et al., 1992), 
presumably as a result of a failure in repressing Oct4, Nanog and other genes in 
differentiating cells. In contrast to Dnm tl, the methyltransferases encoded by 
DnmtSa and DnmtSb do not differentially methylate hemimethylated or 
unmethylated DNA (Okano et al., 1998). Ablation of both of these genes resulted 
in embryonic lethality due to disrupted de novo méthylation during development 
(Okano et al., 1999).
1-2-2-2 Histone m odification
Unlike prokaryotes, eukaryotic DNA is found in complex with proteins in the 
form of chromatin, which permits the packaging of DNA in the nucleus. The 
chromatin structure can be broadly divided into the open euchromatin state 
(typical of areas that are expressed) and the closed heterochromatin (typical of 
areas that are not transcribed). The chromatin subunit is comprised of the
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nucleosome, an octomeric complex made of histone proteins (typically 2 x H2A, 
H2B, H3, H4) wrapped in DNA. Post-translational modifications to the histones 
occur in tail domains that protrude out of the nucleosome and alter the 
chromatin state and thus gene expression (Horn & Peterson, 2006).
Histone acétylation is regulated by histone acetylases and deacetylases, which 
respectively add or remove acetyl groups to lysines. Euchromatin typically 
exhibits acetylated lysines on H4, whereas heterochromatin exhibits 
hypoacetylated H4. The addition of an acetyl modification is therefore largely 
considered to enhance transcription (Grunstein, 1997).
Histone méthylation (regulated by histone methyltransferases) occurs a t lysine 
or arginine residues and, in contrast to acétylation, can both enhance or repress 
gene expression. For example, tri-methylation of lysine 4 on histone H3 
(H3K4me3) is associated with actively transcribed genes, whereas 
tri-methylation on lysine 27 (H3K27me3) occurs at repressed genes (Mikkelsen 
et ah, 2007). Histone modification and DNA méthylation appear to coordinate to 
regulate gene expression, as genome wide analysis in mES cells suggested tha t 
these epigenetic modifications are tightly correlated (Meissner et ah, 2008).
1-2-3 A revised model for reprogramming
Whereas successful reprogramming has been carried out with terminally 
differentiated pancreatic p cells (Stadtfeld et al., 2008a) and B-/T-lymphocytes 
(Eminli et al., 2009; Hanna et al., 2008; Stadtfeld et al., 2012), differentiated 
cells undergo reprogramming at a vastly reduced efficiency compared to their 
stem or progenitor counterparts, at least in the haematopoietic lineage (Eminli
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et al., 2009). Furthermore, clonally expanded terminally differentiated cells 
undergo reprogramming at markedly different rates, supporting the concept of 
required epigenetic alterations that occur in a stochastic manner (Hanna et al., 
2009). It is therefore reasonable to suggest that reprogramming of all cell types 
is possible, but this processing occurs at reduced efficiency in differentiated cells 
since more epigenetic changes are required to achieve a fully reprogrammed 
state. Certainly this combinatorial model (Figure 1-3C) is supported by studies 
that have suggested that persistence of “epigenetic memory” in iPS cells. In 
these experiments, iPS cells retain epigenetic markings of their parental line 
and more readily differentiate back to their parental lineage (Bar-Nur et al., 
2011; Kim et al., 2010; Polo et al., 2010). However, it is possible that 
differentiated cells are amenable to reprogramming, but culture medium that 
supports pluripotent growth impairs the survival of these differentiated cells.
The demonstration that expression of four factors was sufficient for the 
conversion of somatic cells to ones that closely resemble ES cells is extremely 
important for disease modelling and has great potential therapeutically.
1-2-4 Applications of iPS cell reprogramming
The initial derivation of human ES cells had been accompanied with the 
suggestion of their use in regenerative therapy (Thomson et al., 1998). However, 
there are considerable social and ethical issues associated with this, which are 
circumvented by the derivation of human iPS cells (Takahashi et al., 2007).
Patient specific iPS cells have been be used for in vitro modelling of diseases, 
typically following in vitro differentiation, including a number of
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neurodegenerative disorders. Motor neurons derived from human amyotrophic 
lateral sclerosis patients have been used for drug screens (Egawa et al., 2012). 
iPS cell derived cortical neurons have been generated from patients with Down 
syndrome and Alzheimer’s, providing an in vitro model for early onset 
Alzheimer’s (Egawa et al., 2012). These cells could subsequently used with 
previously established drug screen systems for Alzheimer’s neurons (Yahata et 
a l,  2011).
Patient specific iPS cells can also be differentiated in vitro and subsequently 
used for autologous transplantation. Dopamine neurones have been derived 
from iPS and ES cells and transplanted into models of Parkinson’s disease in 
mice, rats and monkeys (Kriks et a l, 2011; Rhee et a l,  2011; Wernig et a l,  
2008b). In a model of retinitis pigmentosa, iPS derived cells can integrate into 
the retina, decreasing visual impairment in mice (Li et a l, 2012).
It was initially noted that mice derived from iPS cells frequently developed 
tumours, the result of continued Myc transgene expression (Okita et a l ,  2007; 
Sommer et a l, 2009). The connection between Myc and cancer is well 
established (Dang, 2012), but increasing evidence suggests a role for the Sox2 in 
tumourigenesis: Recently, amplification of the human gene S0X 2  in lung 
tumours has been observed (Rudin et a l,  2012; Sasaki et a l, 2012). Taken 
together, it is clear that before iPS cells can be used in humans therapeutically, 
their safety must be fully demonstrated.
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1-2-5 Improving IPS cell reprogramming
Various strategies have been tested in murine and human cells to explore safer 
avenues for reprogramming. Concerns over safety initially stemmed from 
tumours in iPS cell derived mice that were driven by the exogenous Myc 
expression introduced during reprogramming (Okita et ah, 2007). However, 
simply reprogramming somatic cells in the absence of the oncoprotein is slower 
and far less efficient (Nakagawa et ah, 2008; Wernig et ah, 2008a). Therefore, 
several strategies were initially used to decrease the risk of Myc driven tumours 
in tissues derived from iPS cells.
A vector carrying tamoxifen inducible Myc permits reprogramming in 
conjunction with other factors; withdrawal of tamoxifen resulted largely in 
inactivity of the transgene (Duinsbergen et ah, 2008). Alternatively, use of 
L-Myc in place of Myc (a related transcription factor with reduced transforming 
capabilities) permitted relatively efficient reprogramming without associated 
tumour formation in iPS derived mice (Nakagawa et ah, 2010). Finally sets of 
transcription factors that did not include Myc, such as human Oct4, Klf4 and 
Lin28, have been used to reprogram human fibroblasts; the addition of Nanog to 
these three vastly improved reprogramming efficiency (Yu et al., 2007).
Alternatively, reducing the number of factors required for reprogramming can 
be achieved by choosing target cells that express high endogenous levels of one 
or more factor. Neural stem and progenitor cells, which express endogenous 
Sox2 at high levels (Ellis et al., 2004), have been used for these studies. Initially, 
reprogramming of murine neural stem and progenitor cells was achieved in the 
absence of Myc, with the remaining three factors (Duinsbergen et ah, 2008;
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Eminli et al., 2008). Further work demonstrated that Oct4, in conjunction with 
either Klf4 or Myc, was sufficient for reprogramming (Kim et al., 2008; Shi et al., 
2008; Silva et al., 2008). Remarkably, Oct4 alone reprogrammed neural stem 
cells from mice (Kim et al., 2009b) or humans (Kim et al., 2009a). Of course, 
these neural cells cannot be readily derived from patients. In contrast, 
kératinocytes can be easily and safely generated and express higher levels of 
Klf4 and Myc than fibroblasts, permitting reprogramming in the absence Myc 
(Aasen et al., 2008). Furthermore, the reprogramming efficiency of human 
kératinocytes is far higher than fibroblasts (Aasen et al., 2008; Maherali et al., 
2008).
Given that viral integration can ablate or enhance gene expression, there was 
concern that genetic lesions might pre-dispose iPS cells to tumours, e.g. via 
inactivation of tumour suppressors. Strategies to decrease the number of 
integrations was achieved by encoding multiple factors on a single construct, 
separated by either an internal ribosomal entry site (1RES) (Pelletier & 
Sonenberg, 1988) or self-cleaving 2A peptides (Donnelly et al., 2001). The 
sequences encoding 2A peptides (typically 16 -  18 amino acids long) cause the 
ribosome to pause during translation and fail to link adjacent amino acids, 
resulting in multiple protein products being translated from a single transcript 
(Donnelly et al., 2001; Ryan et al., 1991). Vectors using either of these 
approaches have been used successfully to program murine and human somatic 
cells (Carey et al., 2009; Kaji et al., 2009; Papapetrou & Sadelain, 2011; Sommer 
et al., 2009). The excision of factors flanked by loxP sites following successful 
reprogramming, may produce iPS cells better suited for therapeutic use 
(Papapetrou & Sadelain, 2011; Soldner et al., 2009).
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Chemicals that either substitute for factors or enhance reprogramming have 
also been used, such as inhibitors of histone modifying enzymes. Valproic acid, a 
histone deacetylase inhibitor, increased reprogramming efficiency and allowed 
for the reprogramming of human fibroblasts with just Oct4 and Sox2 (Huangfu 
et al., 2008a; Huangfu et al., 2008b). Similarly, the methyltransferase inhibitors 
azacitidine and BIX-01294 have been used to increase reprogramming efficiency 
of murine somatic cells (Mikkelsen et al., 2008; Shi et al., 2008). Ascorbic acid 
(vitamin C) also increases the rate, efficiency (Esteban et al., 2009), and quality 
of reprogramming (Stadtfeld et al., 2012).
High throughput screens have been used to identify chemical substitutes for 
specific factors. The Cdkl/Cyclin B inhibitor kenpaullone (Sausville et al., 2000) 
can substitute for Klf4. Furthermore, TGF-p inhibition can replace the 
requirement for Sox2, even in the absence of Myc (Ichida et al., 2009).
Whereas great advances have been made in the generation of iPS cells, the 
precise mechanisms underlying reprogramming are still poorly understood. 
Further understanding may come from a study of how pluripotent cells 
maintain their status in vitro. It has been known for some time that 
maintenance of pluripotent mES cells in vitro requires LIF, provided either by 
feeders (Stewart et al., 1992) or as a supplement to the medium, as well as 
serum. In the absence of serum and in addition to LIF, bone morphogenetic 
protein (BMP)4 is required to prevent differentiation via induction of inhibitor of 
DNA binding (Id)l (Ying et al., 2003a), a member of the helix-loop-helix (HLH) 
family of transcription factors.
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1-3 The Id family of proteins
The studies prior to the identification of Id l were aimed at understanding the 
azacitidine mediated conversion of fibroblasts to myoblasts (Taylor & Jones, 
1979). The high frequency of conversion suggested that a low number of loci 
needed to be modified to induce conversion; a screen for differentially expressed 
transcripts identified MyoD as a candidate factor (Davis et al., 1987). Indeed, 
ectopic expression of MyoD was sufficient to induce the myogenic conversion of 
MEFs (Davis et al., 1987). MyoD has two domains that are required for this 
conversion; a basic region required for interaction with DNA and a HLH domain 
(Murre et al., 1989; Tapscott et al., 1988).
During a screen for other HLH proteins that might regulate erythroid 
differentiation, a novel HLH member Id (herein referred to as Idl) was cloned 
and named after its ability to inhibit DNA binding (Benezra et ah, 1990). Unlike 
other HLH proteins, Id l lacks the adjacent basic domain required for DNA 
binding (Benezra et ah, 1990; Tapscott et ah, 1988) and is highly similar to the 
gene product of emc in Drosophila (Ellis et ah, 1990; Garrell & Modolell, 1990). 
The strong homology of Id l in the HLH region with other family members 
(Figure 1-4) permitted the identification and cloning of Id2 (Sun et ah, 1991), IdS 
(Christy et ah, 1991) and Id4 (Riechmann et ah, 1994).
The Id proteins largely act to negatively regulate basic HLH (bHLH) 
transcription factors by preventing their binding to DNA, typically by 
sequestering E proteins, obligate binding partners of bHLH proteins (Jen et ah, 
1992; Pesce & Benezra, 1998).
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Figure 1-4: Conservation of Id l -  Id4
A: Alignment of mouse Id l -  Id4 protein sequences with region encoding the HLH 
domain denoted. Consensus is indicated by height. B: Phylogram showing 
relationship between Id family members.
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The E proteins (HEB, E2-2 and the E2A gene products, E12, E47 and E2-5) are 
ubiquitously expressed (class I bHLH proteins) and heterodimerise with other 
(tissue restricted class II) bHLH proteins permitting binding to the consensus 
sequence CANNTG (Massari & Murre, 2000; Pagliuca et al., 2000) (Figure 1-5).
Therefore, class II bHLH activity is regulated as a function of the relative 
expression of Id and E proteins: High Id protein levels result in sequestered 
E proteins, preventing the latter from binding to tissue specific bHLH proteins. 
In cells where Id protein levels are low, E proteins are therefore free to 
heterodimerise with class II HLH TFs, permitting their activity (Figure 1-6).
However, interaction with non-HLH domains has been documented, e.g. with 
the Ets family of transcription factors in regulating senescence (see 1-3-2 Id 
proteins and senescence) and telomerase activity (Ohtani et al., 2001; Xiao et al., 
2003). Several lines of evidence exist for Id2 being a direct antagonist of 
retinoblastoma (RB) protein (pRb, the product of Rhl): Ectopic expression of Id2 
in osteosarcoma cells reverses a pRb-mediated block in proliferation (lavarone et 
al., 1994). However, this rescue is dependent on the HLH domain of Id2 and 
interaction appears to be specific to Id2 (and not Id l or Id3) (lavarone et al.,
1994; Lasorella et al., 1996). Furthermore, cross-linking experiments 
demonstrate interaction of ectopically expressed pRb and Id2 in osteosarcoma 
cells (lavarone et al., 1994). Finally, ablation of Id2 expression in Rhl'^'mice 
largely rescues the developmental defects observed in mice deficient for pRb 
alone (Lasorella et al., 2000).
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NeuroD I
NeuroDl
Figure 1-5: E47-NeuroDl binding to DNA
Class I bHLH protein E47 (cyan-blue) binds to DNA as a heterodimer with the 
class II bHLH protein NeuroDl (orange-red). Basic domains (blue and red) are 
required for DNA interaction. Based on structural data of Longo et al. (2008).
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Figure 1-6: Id protein levels determine bHLH activity
A: Id proteins sequester E proteins, preventing heterodimerisation with tissue 
specific bHLH proteins and thus DNA binding. B: When Id proteins are low or 
absent, E proteins can heterodimerise with tissue specific bHLH proteins, bind 
DNA and regulate gene expression.
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Given the conservation of the HLH domain, it is unsurprising tha t there is some 
functional redundancy between Id family members. Id3'^' mice exhibit modest 
defects in B-cell mediated immunity; ectopic expression of Id l  in B cells of these 
mice can restore humoral immunity (Pan et al., 1999). Whereas Idl'^' mice are 
viable (Yan et al., 1997), ablation of both Id l  and Id3 resulted in embryonic 
lethality prior to embryonic day 13.5, due to deficiencies in angiogenesis and 
premature neuronal differentiation (Lyden et al., 1999).
However, Id l and Id3 are not completely redundant: ablation of HEB (which 
encodes an E protein) resulted in neonatal lethality (Barndt et al., 1999). 
Whereas restoration of the Id:E protein balance by ablating Id3'^' in HEB 
deficient mice largely abrogates this lethality, the same is not observed in Idl'^' 
HEB'^' neonates (Barndt et al., 1999), suggesting an incomplete overlap in their 
function.
1-3-1 Regulation of the Id family members
Expression of the Id  family members is tightly regulated during embryogenesis 
romegaand in the adult mouse (Jen et al., 1997). Studying how the Id  expression 
is regulated has revealed transcriptional control in response to extracellular 
cues, particularly from the members of the transforming growth factor (TGF)-p 
super family.
The numerous and diverse TGF- p cytokines control a range of cellular 
mechanisms. Two types of TGF-P receptor are found in the cell membrane. 
Binding of a TGF-p ligand results in heterodimerisation of these two types
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either in a synchronous (typical of BMP ligands) or asynchronous (typical of 
TGF-p or activin ligands) manner. In the case of the latter, ligands bind directly 
to type II receptors, which then heterodimerise with type I receptors (Massague,
1998).
TGF-p receptors signal through the SMAD family of proteins, so named after 
their homology with the gene products of Sma  (C. elegans) and Mothers against 
dpcapentaplegic (Drosophila) (Liu et ah, 1996). The SMAD family is broadly 
divided into three groups based on function: the receptor SMADs which are 
phosphorylated by the type I TGF-p receptor, the common SMAD which binds to 
receptor SMADs and the inhibitory SMADs which antagonise SMAD activation 
(Massague, 1998).
Activated receptors SMADs can bind to two binding sites in the Id l promoter, 
which are both necessary and sufficient to mediate signalling from the TGF-P 
family (Korchynskyi & ten Dijke, 2002; Lopez-Rovira et a l, 2002). Treatment of 
cells with BMP2, BMP4 and BMP? can induce expression of Id l and Id3 at the 
transcriptional level, independent of de novo gene expression (Korchynskyi & 
ten Dijke, 2002; Lopez-Rovira et al., 2002; Nakashima et al., 2001; Yanagisawa 
et al., 2001). TGF-p represses the Id family: Atf3 (which is induced by TGF-P) 
and SMAD proteins bind together at the Id l  promoter to repress expression 
(Kang et al., 2003).
Serum withdrawal resulted in down regulation of Id l, Id2  and Id3 expression 
(Asp et al., 1998). In addition to the effects of BMP withdrawal via the SMAD 
family, it has been proposed that this is due to decreased Egr-1 expression
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(which has a number of serum responsive elements in its promoter) and thus 
decreased Egr-1 binding to the Id  promoters (Tournay & Benezra, 1996). 
Post-translational regulation of the Id family also occurs. Id proteins are 
typically unstable, with reported half-lives between 30-60min (Trausch-Azar et 
al., 2004). Id l, Id2 and Id3 are degraded by the proteasome (Bounpheng et al.,
1999). Proteins are targeted for degradation by addition of a ubiquitin moiety 
(Hershko & Ciechanover, 1998); in the case of the Id proteins, this is conferred 
by the anaphase promoting complex (an E3 ubiquitin ligase), activated by Cdhl 
(Lasorella et al., 2006).
Increased stability of proteins can be achieved by the removal of ubiquitin 
modifications by deubiquitinases (Komander et al., 2009). Increased stability of 
Id proteins mediated by the deubiquitinase USPl (and its binding partner 
WDR48) has been reported in human osteosarcoma lines (Williams et al., 2011). 
Since their identification, growing evidence places the Id family as regulators of 
senescence and functional markers of stem cells.
1-3-2 Id proteins and senescence
Senescence defines a cellular state devoid of proliferation but where metabolic 
activity is retained. Primary cells have a limited life span and proliferate a finite 
number of times before entering this growth arrested state (Hayflick & 
Moorhead, 1961). A range of stimuli including DNA damage and oncogene 
expression can trigger arrest. Senescence is mediated by elevated expression of 
cyclin-dependent kinase inhibitors, pl6^^^'^^ and p21^^^i, which inhibit cell cycle 
progression through the RB and p53 pathways.
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Early observations of senescence were from in vitro experiments and so it was 
possible that the observed growth arrest might be an artefact of cell culture. 
However, given tha t oncogenic stress can trigger arrest and tha t RB and p53 
pathways are frequently inactivated in tumours, it has been suggested that 
senescence can also serve as a tumour suppressive mechanism in vivo (Campisi 
& d'Adda di Fagagna, 2007; Ohtani et al., 2009). Furthermore, ablation of 
senescent p i h i g h  cells in a murine model of aging increased life span and 
delayed the onset of tissue dysfunction (Baker et al., 2011).
A series of in vitro and in vivo experiments in which Id l expression was 
manipulated places it as a regulator of senescence. mice have elevated 
levels of both p i a n d  p21^^^i (Ciarrocchi et al., 2007; Lyden et al., 1999). 
Furthermore, knockdown or ablation of Id l expression resulted in increased 
plgiNK4A levels in primary cells and the premature onset of senescence (Alani et 
al., 2001; Zheng et al., 2004). Conversely, ectopic expression of Id l directly 
inhibited Ets protein activity, thus inhibiting expression of p i ( O h t a n i  et 
al., 2009). Furthermore, inhibition of plO^^ '^^  ^expression via ectopic Id l 
expression delayed senescence in vitro in primary and immortal cell lines (Lee et 
al., 2003; Zheng et al., 2004).
1-3-3 Id proteins as stem  cell regulators
Stem cells persist throughout the adult organism, ensuring maintenance of 
tissue function through regeneration. Consistent with the initial observation 
that Id l blocked MyoD mediated transdifferentiation (Benezra et al., 1990), 
manipulation of Id  expression affects the differentiation potential of a wide 
range of cells.
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Ablation of Id l in haematopoietic stem cells resulted in a defect in self-renewal 
and premature commitment to the myeloid lineage (Cochrane et al., 2009; 
Jankovic et al., 2007). Conversely, ectopic expression of Id l blocked 
differentiation of progenitor cells to the myeloid lineage and impaired B-cell 
development and erythroid differentiation (Kreider et al., 1992; Shoji et al.,
1994; Sun, 1994). Ablation of Id2 blocked the differentiation of progenitor cells 
to natural killer cells, resulting in increased commitment to the T cell lineage 
(Ikawa et al., 2001).
Ectopic expression of Id l or Id3 blocked neurogenesis in vitro, and both 
embryonic and post-natal neurogenesis (Cai et al., 2000; Nakashima et al.,
2001). In contrast, ectopic expression of Id2 promoted neurogenesis (Martinsen 
& Bronner-Fraser, 1998). Using the Idl-Venus transgenic mouse (in which the 
endogenous Id l  locus was modified to encode a functional Id l protein fused to a 
yellow fluorescent protein), Nam & Benezra (2009) identified rare adult neural 
stem cells, which expressed high levels of Id l. Ablation of Id l  and IdS 
expression in these cells resulted in a severe defect in proliferation and impaired 
self-renewal (Nam & Benezra, 2009).
Consistent with these observations, ectopic expression of Id l blocked the 
differentiation of mES cells in vitro (Ying et al., 2003a), though the necessity for 
Id family members in mES pluripotency were until recently unclear.
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1-3-3-1 Id l in mES cells
To test the requirement for Id proteins in the maintenance of in vitro 
pluripotency, wild-type (WT), and IdS'^' mES cells were derived prior to the 
start of the present work. Whereas no overt difference was observed between 
WT and IdS'^' mES cells, IdV^' mES cells formed flatter, more protruding colonies 
that are uncharacteristic of pluripotent mES cells. Idl'^' mES cells also had a 
reduced ability to self-renew, a lower proliferation rate and expressed markers 
of differentiation. Expression of the pluripotency regulator Nanog is lower in 
Id r '' mES cells and ectopic expression of Nanog in these cells resulted in 
restoration to WT mES phenotypes (Romero, 2009).
Preliminary data (Romero, 2009) suggested that higher levels of zinc finger 
E-box binding homeobox (Zeb)l were observed in Id l ’^ ' mES cells than in WT 
cells (Figure 1-7A).
Ectopic expression of Zebl reduced expression of luciferase under the Nanog 
promoter in both WT and IdT^' mES cells (Figure 1-7B). Taken together, these 
data suggested tha t Id l inhibited expression of Zebl, the latter being an 
inhibitor of Nanog expression. However, the mechanism by which Id l regulated 
Zebl remained unclear.
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Figure 1-7: Prelim inary data on the role of Zebl in mES pluripotency
A: Western blot for Nanog, Zebl and Actin in WT and two IdT^' mES cell lines. 
B: Luciferase activity measured 48h after transfection of WT and mES 
with a luciferase reporter driven by a minimal Nanog promoter and either an 
empty vector or one expressing Zebl. Analysed using the Student’s t-test, 
relative to empty vector; p<0.001; ***. From Romero (2009).
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1-4 H ypotheses, aims and objectives of the present work
Growing evidence places the Id family, as central regulators of stem cell 
function in a wide range of lineages. The present work initially focused on the 
recently ascribed role of Id l as a critical regulator of in vitro pluripotency in 
mES cells (Romero, 2009).
Aim 1: Confirm the involvem ent of Zebl in regulation o f pluripotency  
by Id l
Romero (2009) hypothesised that Zebl is an inhibitor of Nanog in mES cells, 
downstream of Id l.
• Repeat measurement of Zebl protein levels in WT and IdT^' mES cells
• Identify alternative antibodies for Zebl
• Assess the specificity of these antibodies for Zebl and cross-reactivity 
against Zeb2
Aim 2: Examine consequences of Id l  or Id3 ablation on reprogram ming  
and bow these genes are expressed during this process
It was hypothesised that Id l would be required for the acquisition of 
pluripotency that occurs during reprogramming, since Id l was required to 
maintain pluripotency in vitro.
• Assess how ablation of either Id l  or Id3 altered efficiency of iPS cell 
reprogramming, with or without feeder cells
• Determine how Id l  and Id3 expression changed during reprogramming
• Characterise changes in Id l mRNA and protein levels during the 
passaging of primary cells towards senescence
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Aim 3: Characterise the post-transcriptional regulation o f Id l during  
senescence
Based on the data generated under aim 2, it was hypothesised that Id l was 
post-transcriptionally regulated as primary cells senesced. To assess this 
hypothesis, the following objectives were set:
• Assess the role of protein turnover on Id l levels by measuring changes in 
Id l protein levels in response to proteasomal inhibition in early and late 
passage MEFs
• Assess the effect of the Id l 3’ untranslated region (UTR) on expression 
levels using a reporter vector
• Identify putative regulatory regions within the Id l 3’ UTR using 
truncation and point mutations in a reporter vector
• Investigate the role of microRNAs (miRNAs) in regulating Id l expression 
by manipulating the activity of miRNAs tha t are predicted to bind to the 
Id l 3’ UTR and measuring changes in Id l protein levels or expression 
from the Id l 3’ UTR reporter vector
• Generate tools to introduce mutations in the endogenous locus encoding 
the Id l 3’ UTR
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Ch a p t e r  2: M a t e r ia l s  a n d  M e t h o d s
2-1 G enotyp ing  of m ice
C57BL/6 WT, 7rfi'^'(Yan et a l,  1997), IdS’'- (Pan et a l,  1999) and Oct4-GFP 
(Lengner et a l,  2007) were maintained by C. Coker in compliance with 
MSKCC’s Institutional Animal Care and Use Committee and the Research 
Animal Resource Center guidelines. To obtain pregnant mice for MEF 
derivation, two female mice ($) and one male mouse (J^ ) were housed in the 
same cage, with females separated as soon as a vaginal plug (indicative of 
copulation) was observed. Mice were genotyped using DNA extracted from tails:
Tail tip snips were incubated at 98°C for 20min in 200pl 0.05M NaOH in a 96 
well plate (BD). Plates were returned to room temperature (RT) and 20pl IM 
Tris-HCl (pH 7.5) added. Ipl was used in a 20pl PCR reaction using 2.5X PCR 
Master Mix (5 PRIME) and primers below (Table 2-1). Genotype was indicated 
by the presence of bands on an agarose DNA gel (see 2-3 Cloning), of the base 
pair (bp) length indicated below.
Gene S equence B and  L eng th
WT
Idl M utant 
Common
TCCTGCAGCATGTAATCGAC
GACGTGCTACTTCCATTTGTCA
GAGACCCACTGGAAAGGACA
~350bp
~600bp
WT
Ids M utant 
Common
CTTGGGACCCTGGGACTCT
GGGGAACTTCCTGACTAGGG
TAATCAGGGCAGCAGAGCTT
~350bp
~500bp
WT
Oct4-GFP M utant 
Common
TGCCAGACAATGGCTATGAG
CCAAAAGACGGCAATATGGT
CAAGGCAAGGGAGGTAGACA
~440bp
~240bp
Table 2-1: P rim ers  used  for geno typ ing  m ice
37
2-2 Cell culture
Cells were, with exceptions described below, maintained in DME medium 
(Dulbecco's Modified Eagle Medium (D-MEM; MSKCC’s Core Media Preparation 
Facility, herein referred to as MSKCC) supplemented with 10% foetal bovine 
serum (FBS), 2mM L-glutamine (MSKCC), lOOU/ml penicillin (MSKCC) and 
lOOpg/ml streptomycin (MSKCC)).
mES cells were maintained in mES cell medium (D-MEM supplemented with 
13.5% ES cell-qualified FBS (Invitrogen), 2mM L-glutamine, lOOpM MEM non- 
essential amino acids (Invitrogen), 1250U/ml leukaemia inhibitory factor (LIE; 
Millipore), lOOU/ml penicillin, lOOpg/ml streptomycin and 143pM
2-mercaptoethanol (Sigma)). Whereas mES cells may be maintained on feeders, 
they can also be cultured in their undifferentiated state on gelatin coated plates 
in the presence of LIE (Ying et al., 2003b). Gelatin coated plates were produced 
by adding 0.1% gelatin (Sigma) in phosphate buffered saline without calcium or 
magnesium (PBS; MSKCC) to plates at O.lml/cm^, incubating at 37°C for lOmin 
and removing excess liquid.
iPS cells, or MEFs that were being reprogrammed, were maintained in iPS 
medium (Knockout D-MEM (Invitrogen), 15% Knockout Serum Replacement 
(Invitrogen), 2mM L-glutamine, lOOpM MEM non-essential amino acids, 
1250U/ml LIE, lOOU/ml penicillin, lOOpg/ml streptomycin and 143pM
2-mercaptoethanol). iPS cells were maintained on feeder cells (mitomycin c 
treated MEFs plated at 15 000 cells/cm^; GlobalStem).
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Cells were maintained at sub-confluence and passaged as follows: cells were 
removed from the plate by washing cells with PBS and incubating with 0.25% 
trypsin, 2mM EDTA in PBS (herein referred to as trypsin; MSKCC) for 5min at 
37°C. Cells were resuspended in appropriate medium and plated.
To preserve cells for extended periods of time outside of culture, stocks were 
frozen and stored in liquid nitrogen. mES cells were frozen in 80% mES cell 
medium, 10% FBS, 10% dimethyl sulfoxide (DMSO; Sigma). All other cell lines 
were frozen in 90% FBS, 10% DMSO. Following resuspension of cells in 
appropriate freezing solution, cryovials (Corning) were stored in a container 
insulated with isopropyl alcohol (Fisher) which, when placed at -80°C, decreased 
the temperature by l°C/min. The next day, cells were transferred to storage in 
liquid nitrogen. Cells were thawed by transferring vials from liquid nitrogen to 
37°C for Imin and resuspending them in appropriate medium. The cell 
suspension was centrifuged at 300 x g  for 5min, resulting cell pellets 
resuspended in fresh medium and plated.
Cells were transfected using Lipofectamine 2000 (Invitrogen) in a 24 well plate 
as follows (reactions were scaled according to number of wells or surface area as 
needed): Ih  prior to transfection, 0.5ml medium without antibiotics was 
replaced. A stock of diluted Lipofectamine 2000 was prepared, at Ipl 
Lipofectamine 2000 in 50pl Opti-MEM (Invitrogen) per well, and incubated for 
2min at RT.
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Meanwhile, DNA was diluted in 50pL OptiMEM. The DNA and Lipofectamine 
2000 OptiMEM stocks were mixed and incubated for 20min at RT. This mixture 
was added directly to the wells.
2-2-1 mES cells
WT and mES cells were derived by E. Romero-Lanman, obtained at 
passage 12 (Romero-Lanman et al., 2012) and maintained for no more than eight 
further passages.
2-2-2 Derivation of MEFs
Pregnant mice were euthanised 13.5 days post-coitum (dpc), where observation 
of a vaginal plug is considered 0.5 dpc, as follows: A mouse was transferred to a 
polystyrene box, CO2 pumped into the box for 4min after which time a cervical 
dislocation was performed. Embryos were removed and individually washed in 
PBS. Under sterile conditions, each embryo was decapitated and eviscerated: all 
visible organs were removed and foetal livers were retained for genotyping 
individual embryos where necessary. Finally, prepared embryos were stored in 
trypsin for 16h at 4°C.
Each embryo was incubated at 37°C for exactly 15min, excess trypsin removed 
and 1ml of pre-warmed D-MEM added. The embryo was disaggregated by 
passing it through a 20 gauge needle (BD) ten times and the resulting cell 
suspension added to a 150mm^ plate containing 20ml of pre-warmed medium. 
This process leads to enrichment of a heterogeneous population of fibroblastic 
cells referred to as MEFs; non-fibroblastic cells are either mechanically removed 
during preparation of the embryo or do not proliferate under these culture
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conditions. Indeed, the medium change 24h after plating removed a considerable 
number of non-viable cells tha t had not adhered. Cells were frozen as described 
above (2-2 Cell culture) once the plate had reached ~90% confluence, usually 
within 48h and considered passage 0.
2-2-3 Generation of iPS cells
A wide variety of methods for generating pluripotent cells from somatic cells 
have been described above (see 1-2-5 Improving iPS cell reprogramming). In the 
present work, two methods of introducing the four factors described by 
Takahashi & Yamanaka (2006) were used: nucleofection (Kaji et ah, 2009) and 
lentiviral transduction (Papapetrou et ah, 2011), both described below.
Regardless of the method used, the somatic cell line used was early passage 
MEFs. After introduction of the four factors (on day -2), the cells were allowed to 
recover, before being plated on gelatin coated plates, and with mitomycin-C 
treated MEFs (Stemgent) where noted. 48h after the introduction of the factors, 
the medium was changed to iPS medium (day 0) and replaced daily.
After the reprogramming process, colonies that exhibited a small, tight and 
round morphology were chosen for further analysis; larger colonies with poorly 
defined, fibroblastic edges were not picked (see Results, Figure 3-7 and Figure
3-8). Colonies were picked using a 22 gauge needle (BD) and added to one well 
in a 24 well plate with feeder cells. Colonies were disaggregated 24h later using 
trypsin, resuspended in fresh medium and propagated on feeders for further 
analysis.
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2-2-3-1 Reprogramming via nucleofection
MEFs were nucleofected using MEF Nucleofector Kit 2 (Lonza) as described by 
Kaji et al. (2009). 2 x 10® MEFs at passage 2 were nucleofected with 5pg of 
linearised pCAG2LMKOSimO (vector and linearization described below; also 
see Figure A-1) using program T-020 on a Nucleofector II (Amaxa) and the MEF 
Nucleofector Kit 2 (Lonza). Nucleofected MEFs were plated at 10,000 cells/cm^ 
on gelatin coated wells. After two days, the medium was removed and replaced 
with iPS medium.
The plasmid pCAG2LMK0Sim0  was constructed by Kaji et al. (2009) and 
obtained from Addgene. pCAG2LMKOSimO encodes human MYC, KLF4, 0CT4 
and S0X2, linked by self-cleaving 2A sequences (Donnelly et al., 2001) followed 
by an internal ribosomal entry site (IRES)-mOrange sequence (Pelletier & 
Sonenberg, 1988). pCAG2LMKOSimO was linearised prior to nucleofection by 
digestion with Pvul (New England Biolabs) and purified using UltraClean 
GelSpin DNA Purification Kit (MO Bio).
2-2-3-2 Reprogramming via lentiviral transduction
The lentiviral vector pLM-fSV2A (see Figure A-2) was constructed by 
Papapetrou et al. (2011) and obtained from E. Papapetrou. Like 
pCAG2LMKOSimO, this vector encodes the four factors linked by self-cleaning 
2A sequences, but does not include a fluorescent protein.
Virus was generated as described by Papapetrou et al. (2011). 293T cells were 
seeded on poly-l-lysine (Sigma) coated plates at 1x10® cells/cm^. Poly-l-lysine 
coating prevents detachment of 293T cells, which are otherwise weakly
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adherent. The cells were transfected with pLM-fSV2A (fôV2A herein), psPAX2 
and VSVG at a ratio of 4:3:1 medium at 0.3|n,g/cm  ^was replaced the next day.
The first of four harvests was made 36h after transfection, with subsequent 
harvests made at 12h intervals. Viral supernatant was stored at 4°C, pooled, 
and centrifuged at 25,000 x g  for 2h at 4°C after the final harvest. Virus was 
resuspended in a small volume of medium to produce viral supernatant 
concentrated 50X, which was used to transduce MEFs with 8pg/ml polybrene, 
typically in one well of a 6 well plate.
2-2-4 Transfection of synthetic miRNA regulators
miRNA mimics are synthetic, double stranded RNA molecules which phenocopy 
increased miRNA expression. mirVana miRNA mimics of miR-381, miR-539-3p 
and a negative control (Ambion) were transfected at 50nM using a reverse 
transfection protocol with Lipofectamine RNAiMAX (Invitrogen).
Locked nucleic acids oligonucleotides (LNAs) are synthetic oligonucleotides that 
can be used to suppress specific miRNA activity (Petersen & Wengel, 2003). 
miRCURY LNA inhibitors (Exiqon) of miR-381, miR-539-3p and a control 
inhibitor were transfected at lOOnM, also using a reverse transfection protocol 
with Lipofectamine RNAiMAX.
Cells were reverse transfected in one well in 24 well format. 3pl RNAiMAX and 
the mimic or LNA were mixed in 1.5ml OptiMEM. After incubation for 15min at 
RT, 4.5ml of medium containing 400,000 MEFs were mixed and plated. Cells 
soon adhered and were transfected with psiCHECK2 2h later.
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2-3 Cloning
DNA was amplified using Phusion Hot S tart II High-Fidelity DNA Polymerase 
(Thermo Scientific). MEF cDNA, produced as described below (2-5 Quantitative 
polymerase chain reaction), was used as a template unless otherwise specified. 
DNA were separated on an agarose (Fisher) gel with 5 x 10 ® % ethidium 
bromide (Fisher) in tris base, acetic acid and ethylenediaminetetraacetic acid 
(TAE) buffer (Fisher). DNA was visualised using a short wave handheld UV 
lamp (Spectroline), excised and purified using the QIAquick Gel Extraction Kit 
(QIAGEN).
DNA was digested using restriction endonucleases (REs; New England Biolabs) 
at 5U/pg for 2h at 37°C. Digested vectors were treated with calf intestinal 
phosphatase (New England Biolabs) at 5U/pg for 15min at 37°C. DNA was 
purified using a QIAquick PCR / Gel Purification Kit (QIAGEN).
Ligation was performed using a total DNA of 25ng in a lOpL reaction with a 
molar vector:insert ratio of 1:5 using T4 ligase (New England Biolabs) for 20min 
at RT. Alternatively, for inserts greater than 2000bp, ligation was performed at 
16°C for 16h. Ligation reactions were transformed into DH5a Z-Competent 
Escherichia coli (Zymo Research Corporation) using heat shock. Briefly, 2pL of 
the ligation reaction was added to 50pL E. coli on ice. After 5min, the E. coli 
were transferred to a water bath and 42°C for 45s and returned to ice for 2min. 
E. coli were resuspended in lOOpL Super Optimal Broth (Invitrogen) and grown 
at 37°C for 30min, while shaking. E. coli were subsequently spread on lysogeny 
broth (LB) agar (Fisher) plates with lOOpg/ml ampicillin and incubated, 
inverted, at 37°C for 16h.
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Colonies were picked and grown in 2ml LB with lOOpg/ml ampicillin at 37°C for 
16h and DNA purified using the Fast Plasmid MiniPrep kit (Fisher) or QIAprep 
Spin Miniprep Kit (Qiagen). Clones were screened by digestion and sequenced 
by the MSKCC DNA Sequencing Core Facility. For larger scale purifications, 
cultures were grown overnight in 200ml LB broth with lOOpg/ml ampicillin and 
purified using the Purelink HiPure Plasmid Maxiprep Kit (Invitrogen).
2-3-1 C loning Zeb expression  co n s tru c ts
The coding region of Zebl and Zeb2 was cloned into pBabe-Flag, a modification 
of the retroviral vector pBabe (Morgenstern & Land, 1990), generously provided 
by L. Beverly. pBabe-Flag (see Figure A-3) encodes a FLAG sequence (Hopp et 
ah, 1988) at the C-terminus of an EcoRI / Xhol site. Zebl and Zeb2 were cloned 
as described using primers and enzymes listed (Table 2-2; see also Figure A-4 
and Figure A-5). Note that since Zeb2 contains endogenous EcoRI and Xhol 
sites, compatible Mfel and Sail sites were introduced to enable cloning into the 
EcoRI / Xhol site of pBabe-Flag.
T arg e t Sequence (5’ -  3’) REs
Zebl g c g c G A A T T C a c c a t g g c g g a t g g c c c c a g g t g
g c g c C T C G A G a g c t t c a t t t g t c t t c t c t t c a g a
EcoRI / Xhol
Zeb2 g c g c C A A T T G a c c a t g a a g c a g c c g a t c a t g
g c g c G T C G A C t t c c a t g c c a t c t t c c a t a t t g t c
Mfel / Sail
Table 2-2: P rim ers  used  for cloning  in to  pB abe-Flag
Introduced RE sites are indicated in upper case
2-3-2 C loning 3’ UTRs in to  psiCHECK2
The plasmid psiCHECK2 (Promega) encodes the Renilla and firefly luciferase 
gene products, downstream of separate constitutive promoters (Figure 2-1).
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p o ly (A )- FireflyRenilla
Figure 2-1: Overview of psiCHECK2
Expression of Renilla and firefly luciferase is from separate, constitutive 
promoters. A multiple cloning site (MCS) is downstream of the Renilla coding 
region, but upstream of a synthetic poly-adenylation signal (poly(A)).
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A multiple cloning site downstream of the Renilla luciferase coding region, but 
upstream of a synthetic poly-adenylation signal, permits the cloning of a 3’ UTR 
into this plasmid. Repression by this 3’ UTR can therefore be ascertained by 
measuring the Renilla luciferase normalised to firefly luciferase activity 
{Renilla’.iixeûy), relative to psiCHECK2 without a cloned fragment (herein 
referred to as no 3’ UTR). The 3’ UTRs of the four mouse Id l family members 
and truncations of mouse Id l were cloned using primers and enzymes listed 
(Table 2-3) from MEF cDNA.
T arg e t S equence (5’ -  3’) RE(s)
Id l 3’ UTR 
(423 bp)
g a t a t a C T C G A G g g c g g c g c a c t g a g g g a c c a
g c g c g c G C G G C C G C t t a t c t a a a g t g t t t g t t t a
Xhol,
Notl
Id2 3’ UTR 
(810 bp)
g a t c t c C T C G A G g c a t t t g g g g a c t t t
g a t a t a G C G G C C G C t t g a t g t c a g a c a c a
Xhol,
Notl
Id3 3’ UTR 
(564 bp)
g a t a t a G C G G C C G C c c c g g t c g t c c t g g c a c c t c
g a t c t c G C G G C C G C c a a a g t g t t c a a a a a t g g t t
Notl
Id4 3’ UTR 
(1127 bp)
g a t a t a C T C G A G g c t g c g a t g g a t g g c c a g g t
g c g c g c C T C G A G g a a t t c a c t c a g a a t c t a t t
Xhol
Id l 3’ UTR 
Truncation 1
g a t a t a C T C G A G g g c g g c g c a c t g a g g g a c c a
g a t a t a G C G G C C G C a a a c t c a c c c c c a t a g a a c t
Xhol,
Notl
Id l 3’ UTR 
Truncation 2
g a t a t a C T C G A G g g c g g c g c a c t g a g g g a c c a
g t c g a c G C G G C C G C t a c a a a a t a t t t c c t c a g a a
Xhol,
Notl
Id l 3’ UTR 
Truncation 3
g a t a t a C T C G A G g g c g g c g c a c t g a g g g a c c a
g a ta t a G C G G C C G C a g g c tg a a a g g tg g a g a g g g
Xhol,
Notl
Id l 3’ UTR 
M utant 1
t c t g a g g a a a t a t t t t g t a t c g t a t a t t a c a a t g a t c a c t g g c t g
c a g c c a g t g a t c a t t g t a a t a t a c g a t a c a a a a t a t t t c c t c a g a
N/A
Id l 3’ UTR 
M utant 3
c t g a g g a a a t a t t t t g t a t t a g a t c t t a c a a t g a t c a c t g g c t g
c a g c c a g t g a t c a t t g t a a g a t c t a a t a c a a a a t a t t t c c t c a g
N/A
Table 2-3: Primers used for cloning 3’ UTRs into psiCHECK2
Introduced RE sites are indicated in upper case
Figure 3-31A and Figure 3-32A illustrate the m utant forms of the Id l 3’UTR
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Point mutations of the Id l 3’ UTR were made using the QuikChange® Site- 
Directed Mutagenesis Kit (Stratagene) using primers listed (Table 2-3). The 
introduction of mutations was confirmed by sequencing and m utant 3’ UTRs 
were sub-cloned into psiCHECK2, preventing random mutations outside the 
desired region from being introduced.
2-8-3 Cloning 3’ UTRs into Bd.LV
The lentiviral vector Bd.LV encodes GFP and mCherry (provided by Brian 
Brown and Luigi Naldini), driven by a single bi-directional promoter (Figure 2-2 
and Figure A-6). The mouse Id l 3’ UTR was cloned using primers and enzymes 
listed below, from MEF cDNA. Note that this is the same full length 3’ UTR 
cloned into psiCHECK2, using different RE sites.
T arge t S equence (5’ -  3’) REs
Id l 3’ UTR 
(421 bp)
g c g c g c A C C G G T t t a t c t a a a g t g t t t g t t t a
g c g c g c G C T A G C a t a a a t g g c a t t t g g g g a c t
Agel, Nhel
Table 2-4: Primers used for cloning 3' UTRs into Bd.LV
Introduced RE sites are indicated in upper case
2-3-4 Cloning miRNA sponges into pTripZ
Sponges are transcripts that inhibit miRNA activity due to the presence of 
multiple miRNA binding sites, therefore decreasing binding to endogenous 
targets. A single sponge unit is complementary to the target miRNA sequence, 
permitting binding at the 5’ and 3’ end. However, three central bases in the 
sponge unit are not complementary, forcing the formation of a bulge during 
miRNA binding which is thought to decrease degradation of the sponge 
transcript (Figure 2-3) (Ebert & Sharp, 2010).
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LTR mCherry 3 ’UTR —Ih LTR
Figure 2-2: Overview of Bd.LV
A lentiviral vector with a single bi-direcitonal promoter that drives expression of 
mCherry and GFP. Agel and Nhel sites downstream of GFP permit the cloning 
of a 3’ UTR into this vector.
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A scrambled sponge was designed using siRNA Wizard v3.1 (Invivogen; 
httn://www.sirnawizard.com/scrambled.nhp). which rearranged nucleotides of 
the miR-381 sponge and ensured that no known miRNA binding sites were 
present.
A graphical overview of the cloning strategy for generating doxycycline inducible 
sponges with six sponge units is shown below (Figure 2-4). Four sponges were 
generate, 6 x scramble, 6 x miR-381, 6 x miR-539-3p and 3 x miR-381, 3 x miR- 
539-3p. A single oligonucleotide with three sponge units was amplified by PCR 
using a common pair of primers (Table 2-5). These double stranded fragments of 
DNA were purified, digested using Sail and Mlul, and cloned into the Xhol / 
Mlul site of the lentiviral vector pTripZ (Open Biosystems). This site is 
immediately downstream of a doxycycline inducible TurboRFP coding region. A 
second round of cloning into the new Xhol / Mlul resulted in an additional three 
units being added to these intermediate vectors.
Nam e Sequence
Forward primer ga ta ta A C G C G T ccg cC T C G A G g a c
Reverse primer g t c G T C G A C g c g g a a t t a c g c g t t a t a t c
mmu-miR-381 
3 X sponge
g a t c g a g t c g a c g t c c a g a g a g c t t a t g t t g t a t a g c g c a g a g a g c t t a g g t
t g t a t a t c g c a g a g a g c t t a a g t t g t a t a g t c c t c g a g g c g g a a t t c g
mmu-539-3p 
3 X sponge
g a t c g a g t c g a c g t c a a a a g a a a t t c g g t t g t a t g g c g a a a a g a a a t t g g c t
t g t a t g t c g a a a a g a a a t t g c g t t g t a t g g t c c t c g a g g c g g a a t t c g
scrambled 
3 X sponge
g a t c g a g t c g a c g t c g a g g a t a a g a g t t c g t a t g a c t a g t t g a a a g t c g a t a
g c g a t t t a a g a a a t g t g c t a a g g a t t g t c a t a c t c g a g g c g g a a t t c g
Table 2-5: O ligonucleotides used  for clon ing  sponges in to  pTripZ
Introduced RE sites are indicated in upper case
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CGGG
mîR-381 3 ’ -  UGUCUCUCGAA AACAU AU -  5 ’
Sponge 5 ’ . . . ACAGAGAGCUU UUGUAUA. . .  3 *
AUA
Figure 2-3: Sponge - miRNA binding
miR-381 binds to the sponge transcript (one sponge unit is shown) with 
complementarity at the 5’ and 3’ end. However, a central region with no 
complementarity forces the formation of a bulged region during binding. The 
seed region, which typically defines target specificity due to sequence 
complementarity, is shown in green. Adapted from Ebert & Sharp (2010).
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Sail
TRE
I
sponge
I
turboRFP
Xhol Mlul
Xhol Mlul
TRE
Xhol Mlul
turboRFP — sponge
TRE I Xhol Mlul
= turboRFP = sponge sponge
PCR 3 X sponge
Digest PCR product 
with Sail /  Mlul
Digest em pty vector  
with Xhol / Mlul
Ligate 3 x sponge  
Digest with Xhol / Mlul
Repeat to increase 
sp onge repeats
Figure 2-4: Cloning of sponges
Cloning strategy for production of sponges (six units) downstream of a doxycycline 
inducible turboRFP, described in the main text (2-3-4 Cloning miRNA sponges into 
pTripZ).
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2-3-5 C loning o f TALENs
TALENs are synthetic REs tha t can be designed to bind to, and introduce double 
strand breaks at, highly specific sequences in DNA (Hockemeyer et al., 2011). 
TALEN pairs bind, one upstream and one downstream of a desired cut site, 
resulting in homodimerisation of the FokI nuclease which is at the C-terminus 
of each TALEN. Double strand breaks can be resolved by error-prone non- 
homologous end-joining (NHEJ), resulting in the introduction or deletion of 
bases (Aniukwu et al., 2008). Therefore, TALENs may be used to introduce 
mutations at specific sites in the genome.
Pairs of TALENs were generated against a predicted miRNA binding site in the 
3’ UTR of Id l, as described by, and using the reagents of, Cermak et al. (2011), 
obtained from Addgene. The TALEN pairs (see below) were designed using the 
TAL Effector-Nucleotide Targeter (http://boglabx.plp.iastate.edu/TALENT/) and 
constructed as described (Cermak et al., 2011).
TALEN TALEN S equence I d l  3’ UTR 
N ucleo tide
Pair 1 NG HD NG NN N I NN NN NX NX NX NG NX NG NG NG 347
HD NX NN HD HD NX NN NG NN NX NG HD NX NG NG
Pair 2 HD NG NN NX NN NN NX NX NX NG NX NG NG NG NG 348
NG HD NX NN HD HD NX NN NG NN NX NG HD NX NG
Table 2-6: S equences of TALENs
The TALENs were assembled with the above protein sequence identifying the 
repeat variable diresidue in each module.
TALEN activity was tested using a lentiviral reporter of DNA repair (Certo et 
al., 2011). A 50bp region of the Id l 3’ UTR was cloned into the Pmel / Notl site 
resulting in a GFP coding region with a premature stop-codon QsaGFP; Figure
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2-5), using an insert tha t was generated by annealing oligos (Table 2-7) with 
5’ phosphorylated bases (Dow et ah, 2012), resulting in DNA with overhangs 
suitable for cloning into a Pmel / Notl site.
Sequence (5’ -  3’; 5’ phosphorylation)
c t t t c t g a g g a a a t a t t t t g t a t t g A A t T C t a c a a t g a t c a c t g g c t g a T A A g c
ggccGCTTATCAGCCAGTGATCATTGTAGAATTCAATACAAAATATTTCCTCAGAAAG
Table 2-7: O ligonucleotides used for cloning into reporter vector
Successful introduction of double strand breaks, followed by NHEJ in ~33% of 
cases results in a frame shift permitting mCherry expression (Figure 2-5).
2-4 AP staining
AP activity was assayed in ES and iPS cells using a Alkaline Phosphatase 
Detection Kit (Millipore), which essentially uses the fluorometric method of 
Vaughan et al. (1971). Briefly, cells were fixed in 4% paraformaldehyde for 
2min, the cells washed with PBS and incubated for 15min at RT with 0.4mg/ml 
Fast Red Violet and Img/ml Naphthol AS-BI phosphate. Cells were rinsed once 
with PBS with 0.05% Tween 20 (Fisher; PBS-T), then with PBS. Intense violet 
staining indicates high AP activity, typically associated with pluripotent cells or 
cells which have initiated reprogramming (Brambrink et al., 2008).
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Out of fram e (t)
* *3=GFP T2Af mCherry^
TALEN recognition site
Double strand break
B ‘3-g f p  T2A  ^ mCherry^
1/3 of NHEJ events
ta^Gppt T2A mCherry
fromeshift
Figure 2-5: Assaying TALEN efficiency
A region encoding a TALEN recognition site is present in a GFP open reading 
frame with a premature stop codon ysaQFP), which is separated from an out-of­
frame (t) 2A self-cleaving peptide (T2A) and mCherry. NHEJ events with result 
in one of three events, with equal probability:
• A frameshift that results in mCherry expression
• A frameshift that does not result in mCherry expression
• No change in reading frame 
Adapted from (Certo et al., 2011).
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2-5 Q uantitative polymerase chain reaction
Quantitative polymerase chain reaction (qPCR) was used to quantify mRNA 
levels. Total RNA was extracted using RNEasy Mini Kit (Qiagen). 0.1 — Ipg 
RNA was reverse transcribed using Superscript III First-Strand Synthesis 
System (Invitrogen) using oligo(dT)2o primers.
For analysis of Zeb expression, Taqman was used: qPCR was performed in a 
lOpL reaction volume using Taqman Universal MasterMix II, with UNG 
(Applied Biosystems), Taqman primers (Applied Biosystems) for murine Zebl 
(Mm00495564_ml), Zeb2 (Mm00497193_ml) and normalised to TATA binding 
protein transcript (Mm00446973_ml) in a 384 well plate (Applied Biosystems) 
read using a 7900HT Fast Real-Time PCR System (Applied Biosystems).
For other analyses, SYBR Green was used: qPCR was performed in a lOpL 
reaction volume using SYBR Green Master Mix (Applied Biosystems) and 
primers pairs (Table 2-8), normalised to Gapdh.
Relative quantification of mRNA was calculated using the AACt method. A 
single peak in the melt curve following the qPCR reaction was observed for all 
primer pairs. Furthermore, a single band was observed when each qPCR 
product was run on an agarose gel, corresponding to the predicted size. Taken 
together, these data suggested that each primer pair was specific for its target. 
Primers were also tested using a no reverse transcriptase control (the enzyme 
required for cDNA synthesis) to confirm tha t the observed qPCR product was 
amplified from cDNA and not genomic DNA.
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G ene (mouse) Sequence R eference
Idl GAGTCTGAAGTCGGGACCAC
TTTTCCTCTTGCCTCCTGAA
(Mukherjee et al., 2 0 1 0 )
Ids CGACCGAGGAGCCTCTTAG
GGACGCGATAGGGAAGACC
(Spandidos et al., 2 0 1 0 )
Nanog AGGGTCTGCTACTGAGATGCTCTG
CAACCACTGGTTTTTCTGCCACCG
(Chen et al., 2006)
Gapdh GCACAGTCAAGGCCGAGAAT
GCCTTCTCCATGGTGGTGAA
(Chen et al., 2006)
Table 2-8: P rim ers  used  for qPCR 
2-6 A nalysis of p ro te in  expression
Protein expression in lysed cells was measured using sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE), followed by western blotting.
2-6-1 S tock so lu tions
Solutions were prepared using deionised water (dHzO; Milli-Q) and stored at RT 
unless otherwise stated.
• Lysis buffer: Radioimmunoprecipitation assay buffer (50mM Tris 
(Sigma), 150mM NaCl (Sigma), 0.1% SDS (Sigma), 0.5% Sodium 
deoxycholate (Sigma), 1% Tergitol (Sigma) (Alcaraz et al., 1990)), 
supplemented with IX EDTA-free protease inhibitor cocktail (Roche). 
Stored at 4°C.
• 5X Laemmli sample buffer: GOmM Tris-Cl (pH 6.8), 2% SDS, 30% 
glycerol, 0.1% bromophenol blue. 5% 2-ME was added immediately prior 
to use.
• 4X separating buffer: 64g Tris, 0.4% SDS in 500ml dHgO (pH8.8).
• 4X stacking buffer: 30.5g Tris, 0.4% SDS in 500mL dHgO (pH6.8)
• lOX tris glycine buffer: 30.3g Tris Base, 144.Ig Glycine in 11 dHgO
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2-6-2 Cell lysis
Cells were detached from the plate with trypsin, resuspended in appropriate 
medium and centrifuged at 300 x g  for 5min. Medium was aspirated, the cell 
pellet resuspended in ice cold PBS and centrifuged again at 300 x g. PBS was 
aspirated and the cell pellet stored at -80°C for at least 20min. Frozen cell 
pellets were later resuspended in ice cold lysis buffer and incubated on ice for 
20min. Debris was removed by centrifugation at > 13,000 jcg for lOmin at 4°C. 
The supernatant was transferred to a new tube, protein concentration 
quantified and cell lysates stored at -20°C.
2-6-3 M easuring protein concentration
Protein concentration was measured using BCA Protein Assay Reagent (Thermo 
Scientific) against bovine serum albumin (BSA) (0.2 -  2mg/ml in lysis buffer; 
New England Biolabs). Cell lysates were diluted 1:10 in lysis buffer and 
concentration of each sample measured in duplicate, in 96 well format. 20pl of 
diluted lysate was mixed with 200|li1 of assay reagent. After incubation for 
20min at 37°C, absorbance at 562nm was measured using a Synergy 2 plate 
reader (Bio-Tek).
2-6-4 SDS-PAGE
10% or 15% SDS-PAGE gels were cast using glass plates, casting cassettes and 
combs (Bio-Rad). Separating gels were mixed and cast covered with a small 
volume of butanol (Fisher). Once set, the gel was rinsed with dH20 and a 
stacking gel cast in the presence of a comb.
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10% 15% S tack ing
30% Acrylamide/Bis solution (Bio-Rad) 5.07ml 7.65ml 1.25ml
4X separating buffer 3.78ml 3.78ml -
4X stacking buffer - - 1.89ml
dHgO 6.12ml 3.51ml 4.37ml
25% ammonium persulfate (APS; Sigma) 60gl 60|il 39ml
Tetrametbyletbylenediamine (TEMED; Fisher) 9gl 9gl 21ml
Table 2-9: Com position o f sep a ra tin g  an d  s tack in g  gels
Prior to SDS-PAGE, Laemmli sample buffer was added to cell lysates at IX and 
samples boiled for 5min. Proteins were separated on a SDS-PAGE gel in 
running buffer (IX tris-glycine buffer supplemented with 0.1% SDS) and run at 
lOOV for 90min.
2-6-5 W estern  b lo ttin g
The gel was transferred to a PVDF membrane (Millipore) at a lOOV for 75- 
90min in transfer buffer (IX tris-glycine buffer supplemented with 20% 
methanol; Fisher). Membranes were blocked, washed and probed with 
antibodies (Table 2-10) on a shaking platform (Hoefer):
Membranes were blocked in 3% BSA in PBS-T at room temperature (RT) for lb . 
Primary antibodies were diluted in 0.3% BSA in PBS-T at the concentrations 
below and incubated at 4°C for 16b. Membranes were washed after primary 
incubation with PBS-T (3 x 5min). Horseradish peroxidase (HRP) conjugated 
secondary antibodies against rabbit or mouse IgG (GE) were diluted in 0.3% 
BSA in PBS-T at 1:10,000 and incubated at RT for 30m. Membranes were
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washed (3 x 5min), excess liquid removed and ECL-plus (Amersham) added and 
incubated for 5min. Film (Kodak) was exposed to the film and developed.
Alternatively, membranes were blocked in Odyssey Blocking Buffer (LI-COR) at 
RT for lb. Primary antibodies were diluted in Odyssey Blocking Buffer with 
0.1% Tween and incubated with the membrane at 4°C for 16b. Membranes were 
washed in PBS-T (3 x 5min). Secondary antibodies (IRDye 800CW Goat anti- 
Rabbit IgG; IRDye 680RD Conjugated Goat anti-Mouse IgG; LI-COR) were 
diluted at 1:10,000 in Odyssey Blocking Buffer with 0.1% Tween and 0.02% SDS 
and incubated with the membrane for 30min which gentle agitation.
Membranes were washed with PBS-T (2 x 5min) and with PBS (1 x 5min). The 
wet membrane was scanned using an Odyssey Infrared Imager (LI-COR).
Antibody (Product code, vendor) Dilution HRP IRDye
Idl (BCH-1, Biocbeck) 1 1,500 X
Nanog (ab70482, Abeam) 1 1,000 X
Tubulin (T4026, Sigma) 1 6,000 X X
Zebl (antibody I) (NBllO-37255, Novus) 1 1,000 X
Zebl (antibody II) (NBPl-05987, Novus) 1 2,000 X
Zeb2 (ab25837. Abeam) 1 1,000 X
Table 2-10: Antibodies used for w estern blotting
2-7 Flow cytometry
MEFs were analysed for fluorescent protein expression by flow cytometry. Cells 
were detached using trypsin, resuspended in medium and centrifuged at 300 x g 
for 5min. Cells were resuspended in cold PBS, centrifuged at 300 x g  for 5min 
and resuspended in 0.5 — 1ml of 1% FBS in cold PBS with Ipg/ml 
4',6-diamidino-2-pbenylindole (DAPI). DAPI is used as a viability dye and is
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excluded by live cells (Gordon et al., 2003), permitting the setting of gates to 
exclude dead cells from analysis. Samples were analysed using a FACSCalibur 
(BD), CyAn (Cytomation) or an LSR II (BD) flow cytometer.
MEFs undergoing reprogramming were detached using Accutase (Sigma) with 
incubation for 15min at 37“C and cells processed as described above. Accutase is 
often used to cells to preserve cell surface markers (Kriks et a/., 2011; Lee et al., 
2009). Cells were incubated with an antibody against SSEAl conjugated to 
allophycocyanin (R&D) for 15min at 1:1,000, centrifuged at 300 % g for 5min and 
resuspended in 0.5ml of 1% FBS in cold PBS with Ipg/ml DAPI. Cells were 
sorted using a Cytomation MoFlo (BD) by the MSKCC Flow Cytometry Core 
Facility.
2-8 Luciferase assays
Cell lines were transfected with psiCHECK2 (50ng DNA per cm^) using 
Lipofectamine 2000 as described above (2-2 Cell culture) and Rezii/Zaifirefly 
activity assayed using the Dual-Luciferase® Reporter Assay System (Promega), 
measured on a Microplate Lumiometer (Veritas). The cells are lysed in passive 
lysis buffer (Promega) and transferred to a 96 well white assay plate. For each 
well, the luminometer first adds substrate for Firefly luciferase (in LAR II 
Buffer) and measures luminescence. A second substrate is added to the same 
well for Renilla luciferase, as well as a quencher for the first reaction (Stop &
Glo buffer) and luminescence is measured once again.
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2-9 Assaying TALEN activity
MEFs were transduced as described above (2-2-S-2 Reprogramming via 
lentiviral transduction), though without centrifugation, and selected with 
2.5pg/ml puromycin for 48h. TALEN pairs or empty vector were transfected into 
these MEFs (0.2pg DNA per cm^). Medium was changed 16h after transfection 
and cells maintained for 3d at 30°C then 6d at 37°C.
2-10 Data analysis
Statistical analysis was carried out using Prism 5.0c (GraphPad). Statistical 
significance was measured using the Student’s t-test (for comparing two 
samples) or analysis of variance (ANOVA; for comparing more than two 
samples), and indicated: *, p<0.05; **, p<0.01; ***, p<0.001; NS, p>0.05.
Flow cytometry data was analysed using Flow Jo 9.5.1 (Tree Star).
AP staining was quantified using Imaged (NIH): scanned images of AP stained 
plates were separated into three colour channels using “Split Channels”. The 
green channel was converted to a monochromatic image using “Threshold” and 
then quantified using “Analyse Particles”. Levels of AP staining in MEFs were 
relative to WT, arbitrarily set at 1.
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Ch a p t e r  3: R e su l t s
3-1 Re-evaluating the role of Zebl in Nanog regulation
Ablation of Id l expression in mES cells resulted in premature differentiation 
and a defect in self-renewal (Romero-Lanman et al., 2012). Whereas IdT^' mES 
cells express decreased levels of Nanog compared to WT cells (Romero-Lanman 
et al., 2012), it remained unclear why Nanog is repressed in the absence of Id l.
Preliminary data suggested that Zebl expression is higher in IdV^' mES cells, 
resulting in repression of Nanog (Figure 1-7). The initial focus of the present 
work was therefore to understand how Id l regulated Zebl to maintain 
pluripotency in mES cells. Since the Id family of proteins typically regulate 
genes at the transcriptional level by modulating bHLH TF activity (see 
Introduction), expression of Zebl, and a closely related gene Zeb2, was analysed 
in WT and IdV^' mES cells by qPCR.
Relative Zebl mRNA levels were modestly decreased in Idl'^' mES cells (0.54X; 
p<0.01; Figure 3-1). In contrast Zeb2 expression is >20 fold higher in these cells 
(p<0.001; Figure 3-1). Furthermore, the Zebl antibody (NBllO-37255, Novus; 
herein referred to as Zebl antibody I) previously used to characterise expression 
in WT and Idl'^' mES cells (Figure 1-7) was raised using an epitope with 100% 
identity between both Zebl and Zeb2 (Figure 3-2).
Taken together, these data suggested that the band previously observed by 
Romero (2009; Figure 1-7A) may have been Zeb2, and not Zebl. The specificity 
of this antibody for these two proteins was therefore tested.
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Figure 3-1: Zebl  and Zeb2 expression in mES cells
qPCR analysis of Zebl and Zeb2 expression, normalised to TATA-binding 
protein transcript, in WT and Idl'^' mES cells. Mean ± standard error (SE) 
shown for triplicate technical repeats. Analysed using the Student’s t-test: 
p<0.001 (***); p<0.01 (**). Representative of two independent experiments.
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Zebl MADGPRCKRRKQANPRRN. . .
Zeb2 MKQPIMADGPRCKRRKQANPRRK.. .
Figure 3-2: Alignment of the N-terminus of mouse Zebl and Zeb2
The Zebl antibody (I) previously used to characterise Zebl expression was 
raised using an epitope with a sequence found in a region of 100% identity (red 
bar) at the N-terminus of mouse Zebl (NP_035676.1) and Zeb2 (NP_056568.2).
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The retroviral vector pBabe-Flag with the coding region for mouse Zebl and 
Zeb2 were transfected into 293T cells and protein expression analysed by 
western blot. Many bands were observed when the membrane was probed with 
the Zebl antibody (I). Whereas Romero (2009) reported differentially expressed 
protein in these cells using this antibody, it is not clear at what migration these 
bands were observed. Differential expression of a protein at ~75kDa was 
observed between WT and IdV^' mES cells, this band was not observed in any of 
the 293T cell lines (Figure 3-3). Furthermore, the predicted weight of mouse 
Zebl is larger at ~122 kDa (Wilkins et al., 1999). It is therefore unclear what 
these bands actually represent. However, when a duplicate membrane was 
probed with a newer Zebl antibody (NBPl-05987, Novus; herein referred to as 
Zebl antibody II), a single band was observed at ~100 kDa in 293T cells 
transfected with pBabe-Zebl, but not in cells transfected with pBabe-Empty or 
pBabe-Zeb2 (Figure 3-4). Furthermore, a single corresponding band was 
observed in WT and Idl'^' mES cells at equal intensities (Figure 3-4).
Zeb2 expression in human tumour lines has been analysed using a commercially 
available antibody (Beltran et al., 2008). Mouse Zeb2 has a predicted weight of 
137 kDa (Wilkins et al., 1999) but has been reported to run at ~160 kDa 
(Beltran et al., 2008; Xia et al., 2010). A major band was observed at ~160 kDa 
in 293T cells which ectopically expressed mouse Zeb2 that was absent from 
control 293T cells (Figure 3-5). Bands at a similar migration were absent in 
mES lysates, though intense bands were observed below 100 kDa at equal 
intensities between WT and I d l ’^ ' mES cells (Figure 3-5).
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(NB110-37255)
250 kDa
kDa
kDa
75 kDa
50 kDa
37 kDa
25 kDa
Figure 3-3: Analysis of protein expression using Zebl antibody I
Western blot for Zebl in WT and mES cells, and 293T cells. 293T cells 
were transfected with pBabe-Flag (pBabe) with no insert (Empty) or the coding 
regions for Zebl or Zeb2. The membrane was probed with the Zebl antibody (I), 
as used by Romero (2009). Representative of two independent experiments.
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Figure 3-4: Analysis of protein expression using Zebl antibody II
Western blot for Zebl and Tubulin in WT and mES cells, and 293T cells. 
293T cells were transfected with pBabe-Flag (pBabe) with no insert (Empty) or 
the coding regions for Zebl or Zeb2. The membrane was probed with an 
alternative Zebl antibody (II). Representative of two independent experiments.
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Figure 3-5: Testing a Zeb2 antibody for western blotting
Western blot for Zeb2 in WT and IdV^' mES cells, and 293T cells. 293T cells 
were transfected with pBabe-Flag (pBabe) with no insert (Empty) or the coding 
regions for Zeb2.
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No other antibodies against mouse Zeb2 were commercially available when 
these experiments were carried out. These data suggested that Zebl is not 
differentially expressed in WT and and does not support a hypothesis that 
Id l inhibits Zebl expression to maintain pluripotency of mES cells (Romero, 
2009). Whereas it remained unclear how Id l maintained Nanog expression and 
thus pluripotency in mES, it led to the question of what role Id l played during 
the acquisition of pluripotency by somatic cells which occurs during 
reprogramming.
3-2 Is Id l required for the acquisition of pluripotency?
MEFs and other somatic cells can be reprogrammed to the pluripotent state by 
the ectopic expression of four transcription factors: MYC, KLF4, 0CT4 and 
S0X2 (Takahashi & Yamanaka, 2006). Once the factors are introduced, somatic 
cells are maintained in conditions that support pluripotent growth (Takahashi 
& Yamanaka, 2006). Nucleofection was initially used to introduce the factors 
into somatic cells since this method introduces few genomic alterations (Kaji et 
al., 2009). However, before assessing the requirement of Id l for reprogramming, 
this method was used with WT MEFs to ensure that iPS cells could be 
generated using the available reagents.
3-2-1 Generation of IPS cells by nucleofection
The vector pCAG2LMKOSimO encodes the four factors, linked by self-cleaving 
2A sequences, and mOrange downstream of an 1RES element (Kaji et al., 2009). 
WT MEFs were nucleofected without a plasmid (mock) or with a linearised 
vector. Following nucleofection, cells were transferred to gelatin-coated plates. A 
small aliquot (<100,000 cells) were plated on an uncoated plate for analysis of
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mOrange expression by flow cytometry to estimate nucleofection efficiency. After 
48h, efficiency ranged between 1.90 -  6.68%; mock nucleofected cells did not 
express the fluorescent protein (Figure 3-6). The cells plated on gelatin were 
switched to iPS medium 48h and replaced daily. A wide range of colonies was 
observed on plates: larger, poorly defined colonies were ignored, whereas those 
that were small and round (and thus exhibited morphology representative of 
mES cells) were picked and propagated on feeder cells (Figure 3-7).
An iPS line generated from WT MEFs by nucleofection was characterised for 
mES characteristics. The iPS line was maintained on feeders and exhibited 
morphology indistinguishable from WT mES (Figure 3-8).
mES cells typically exhibit high AP activity (Brambrink et ah, 2008). iPS cell 
colonies stained intensely for AP activity, whereas the feeder cells that they 
were cultured on exhibited low AP levels (Figure 3-9).
mES cells also express high levels of the pluripotency regulator Nanog 
(Chambers et al., 2003). Whereas Nanog protein expression was not detected in 
the parental MEF line, expression was observed in iPS cells generated from 
MEFs and mES cells (Figure 3-10). Unequal loading (as indicated by Tubulin 
levels) was observed, but the data suggests that Nanog protein levels may be 
lower in this iPS line compared to mES cells.
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Figure 3-6: Nucleofection efficiency of pCAG2LMKOSimO in MEFs
WT MEFs were nucleofected with no plasmid (Mock) or pCAG2LMKOSimO. The 
number of cells expressing mOrange after 48h was measured by flow cytometry 
to estimate nucleofection efficiency. Percentage of mOrange positive cells ranged 
from 1.90 — 6.68 over five independent experiments.
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Figure 3-7: Representative iPS colonies
Representative lOX phase contrast images of iPS colonies prior to picking. Only 
colonies that exhibited mES morphology were picked and propagated for further 
analysis.
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Figure 3-8: Morphology of a derived iPS line
Representative lOX phase contrast microscopy images of WT mES and WT iPS 
cells, grown on feeder cells.
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Figure 3-9: AP activity in an iPS line
Representative 5X phase contrast microscopy image of AP stained iPS cells 
grown on feeder cells.
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Figure 3-10: Expression of Nanog in an iPS line
Western blot for Nanog and Tubulin in early passage WT MEFs, WT mES and 
WT iPS cells.
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To assess the role of Id l in reprogramming MEFs were derived from an Ç 
crossed with an 6'. Idl'^' MEFs were nucleofected with pCAG2LMKOSiO, 
but in contrast to WT MEFs which continued to proliferate after nucleofection, 
Idr^' MEFs stopped dividing soon after both nucleofection with 
pCAG2LMKOSiO or when mock nucleofected, and exhibited a senescent 
morphology (Figure 3-11). Since Idl'^' MEFs did not tolerate nucleofection, an 
alternative strategy for reprogramming had to be used.
3-2-2 Generation of iPS cells by viral transduction
Lentiviral transduction is commonly used for reprogramming and was used as 
an alternative to nucleofection to introduce the four factors into MEFs herein. 
The lentiviral vector fSV2A encodes the four factors separated by self-cleaving 
2A peptides, expressed from a PGK promoter, and results in integration flanked 
by loxP sites (Papapetrou & Sadelain, 2011). In contrast to pCAG2LMKOSiO, 
fSV2A does not encode a fluorescence protein and thus transduction efficiency 
cannot be measured (Kaji et al., 2009; Papapetrou & Sadelain, 2011).
3-2-3 Id l and Id3 deficiency impairs reprogramming
WT, IdV^' and Id3'^' MEFs were derived from three separate mouse crosses: WT 
$ X WT S, Idr^' $ X Idr^' S, and IdS'^' $ x M3'^' S- MEFs (n=3 per genotype) were 
transduced and re-plated 24 hours later on a gelatin coated plate. 48h after 
transduction, the medium was changed to iPS medium and replaced daily. After 
10 days, the cells were fixed and stained for AP activity, which is induced early 
in reprogramming (Brambrink et al., 2008). The number of AP positive colonies 
was reduced in Idl'^' (15.4%) and Id3'^' (24%) MEFs compared to WT MEFs 
(p<0.01; Figure 8-12).
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Figure 3-11: Response oildT^' MEFs to nucleofection
lOX phase contrast microscopy images of WT and Idl'^' MEFs seeded at the 
same density after nucleofection with pCAG2LMKOSiO, six days after plating. 
Representative of two independent experiments.
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Figure 3-12: and Id3'^ ~ MEFs reprogram at reduced efficiency
WT, Idr''' and Id3'^' MEFs (n=3 per group) were transduced, plated on gelatin 
and underwent reprogramming for lOd. A: Cells were fixed and stained for AP 
activity. B: Estimation of the relative number of AP positive colonies (mean ± 
SE). Analysed using ANOVA with Dunnett’s post test compared to WT: p<0.01 
(**). Representative of two independent experiments.
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3-2-4 Rescuing the deficiency in reprogramming observed in MEFs
Somatic cells that are being reprogrammed are often maintained on a feeder 
monolayer of non-proliferative MEFs (Takahashi & Yamanaka, 2006). In the 
case of reprogramming MEFs, this is not required since cells that do not initiate 
reprogramming can act as feeders (Choi et al., 2011). However, when comparing 
MEFs lines, differences in reprogramming ability may be a result of differences 
in feeder cell activity.
Furthermore, in the experiments described above, MEFs were derived from 
unrelated mice. To ensure that genetic differences independent of genotype were 
not contributing to the observed deficiency, WT and IdV^' MEFs were derived 
from littermates (n=3 per group), obtained by crossing an Idl'^^' $ x Idl^^' S,  and 
transduced as described above. To control for the effects of feeder cell genotype 
on reprogramming, transduced cells were plated on gelatin coated wells with 
mitomycin C treated WT feeder cells. MEFs underwent reprogramming for lOd 
after which time they were fixed and stained for AP activity. In the presence of 
feeders, no difference in reprogramming efficiency was observed between WT 
and IdT^' MEFs (p>0.05; Figure 3-13), in contrast to the reprogramming 
deficiency observed in Id  deficient cells in the absence of feeders (Figure 3-12).
Mice in which the expression of Id family members can be conditionally altered 
have been generated. These include mice in which the Id l, Id2 or IdS  is flanked 
by with loxP sites, permitting tamoxifen inducible excision via CreER (Niola et 
a l, 2012).
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Figure 3-13: Feeder cells rescue the observed deficiency in MEFs
WT and MEFs (derived from littermates; n=3 per group) transduced with 
fSV2A underwent reprogramming for lOd on feeder cells. A: Cells were fixed 
and stained for AP activity, B: Estimation of the relative number of AP positive 
colonies (mean ± SE). Analysed using the Student’s t test: p>0.05 (NS). 
Representative of two independent experiments.
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Mice have also been generated to have drug inducible Id l expression via 
constitutive expression of the reverse tetracycline transactivator and Id l driven 
from a promoter with tetracycline operator concatemers (Nair et al., 2010). An 
understanding of how Id l expression changed during reprogramming may lead 
to a defined program by which Id l could be conditionally altered at the 
appropriate time and thus increase the efficiency of reprogramming.
3-3 M easuring  expression  of I d l  an d  Xd3 d u rin g  rep ro g ram m in g
The reprogramming of MEFs starts with a heterogeneous population of cells and 
proceeds in an asynchronous and stochastic manner. Therefore, analysis of the 
entire population of cells following expression of one or four factors was used to 
consider immediate changes in Id l and Id3 expression. Analysis of changes later 
in reprogramming was achieved by sorting cells into separate populations based 
on progress through the defined stages of reprogramming.
3-3-1 Are I d l  o r Id3 reg u la ted  early  in  reprogram m ing?
Lentiviral vectors encoding a single factor were obtained. Each of these four 
vectors encoded a factor, linked by a 2A self-cleaving peptide to different 
fluorescent proteins (Papapetrou et al., 2009). MEFs were transduced with 
either fSV2A or a vector encoding one factor to assess if Id l or Id3 are 
differentially regulated during the initiation of reprogramming. After 48h, an 
aliquot of cells transduced with single factors was analysed by flow cytometry 
for expression of fluorescence protein and thus the factor: 0CT4 (66.0%), KLF4 
(92%), 80X2 (67.3%) and MYC (48.5%), (Figure 3-14).
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Figure 3-14: Analysis of fluorescent protein expression in MEFs
MEFs were lentivirally transduced with vectors encoding a single factor linked 
via self-cleaving 2A peptides to a fluorescent protein. Analysis of violet-excited 
GFP, mCherry, mCitrine and mCerulean was carried out by flow cytometry on 
transduced cells (blue) and compared to untransduced cells (red). Percent of cells 
expressing a fluorescent protein and thus the factor is shown.
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RNA and protein was extracted from the remaining cells and expression of Id l 
and Id3 compared to untransduced MEFs. Id l transcript levels did not change 
in response to ectopic expression of the four factors, or of 0CT4 or KLF4 alone 
(p>0.05; Figure 3-ISA). Modest changes in Id l transcript levels occurred in 
MEFs transduced with vectors encoding either S0X2 (1.13X, p<0.05) and MYC 
(0.56X, p<0.001) relative to untransduced MEFs (Figure 3-15A). However, no 
change in Id l protein expression was observed (Figure 3-15B).
Id3 transcript levels did not change in response to ectopic expression of 0CT4 or 
80X2 alone (p>0.05; Figure 3-16A). Very modest changes in Id3 transcript levels 
were observed in MEFs transduced with vectors encoding KLF4 (1.38X; 
p>0.001), MYC (0.70X, p>0.001) or the four factors (0.77X; p>0.001) relative to 
untransduced MEFs (Figure 3-16A). No change in Id3 protein levels was 
observed in transduced MEFs (Figure 3-16B)
Taken together, these data suggested that ectopic expression of the four factors 
did not induce expression of Id l or Id3 very early in reprogramming. However, it 
was remained unclear how expression of Id l and Id3 changed as reprogramming 
progressed past this initial stage.
8-8-2 Are Id l or IdS induced at later stages in reprogramming?
The reprogramming of MEFs is a stochastic process that starts from a 
heterogeneous population and so will result in a mixed population of cells th a t 
have reached different stages of reprogramming at a single time point.
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Figure 3-15: Id l expression after four factor expression
MEFs were transduced with vectors encoding one factor (0CT4, KLF4, S0X2 or 
MYC) or all four factors (OKSM); RNA and protein was extracted 48h after 
transduction. A: qPCR for Id l normalised to Gapdh (mean ± SE), relative to 
untransduced MEFs. Analysed using ANOVA with Dunnett’s post-test: 
p<0.05 (*); p<0.001 (***). B: Western blot for Id l and Tubulin in the same 
samples. Representative of two independent experiments.
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F igure  3-16: IdS expression  a fte r  four fac to r expression
M E Fs w ere tra n sd u c e d  w ith  vecto rs encoding one fac to r (0C T 4, K LF4, S 0X 2  or 
MYC) or a ll four fac to rs  (OKSM); RNA an d  p ro te in  w as e x tra c te d  48h  a fte r  
tra n sd u c tio n . A: qPC R for IdS n o rm alised  to  G apdh  (m ean  ± SE), re la tiv e  to 
u n tra n sd u c e d  M E Fs. A nalysed  u s in g  ANOVA w ith  D u n n e tt’s po s t-tes t: 
p<0.001 (***). B: W este rn  b lo t for IdS a n d  T u b u lin  in  th e  sam e sam p les. 
R e p re se n ta tiv e  of tw o in d ep e n d e n t experim en ts .
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At an intermediate stage of reprogramming, MEFs express the cell surface 
marker SSEAl. Late in reprogramming, the endogenous Oct4 locus is 
demethylated, permitting gene expression (Brambrink et al., 2008; Stadtfeld et 
al., 2008b). Cells were therefore sorted at day 18 point into three groups using 
an antibody against SSEAl and MEFs that expressed GFP from the endogenous 
Oct4 locus via an 1RES element downstream of the Oct4 coding region (Lengner 
et ah, 2007): early (no SSEAl expression), intermediate (SSEAl expression 
alone) and late (SSEAl and GFP expression) stage reprogramming (Figure 
3-17).
Protein and RNA was extracted from these three populations as well as the 
parental MEF line prior to transduction (referred to as MEF, day -2), a mES line 
and the iPS line characterised above (Figure 3-8, Figure 3-9, Figure 3-10).
Nanog expression is typically restricted to pluripotent cells and is induced 
during reprogramming (Brambrink et al., 2008; Chambers et al., 2003). To 
ensure that MEFs were successfully separated into different stages of 
reprogramming, Nanog mRNA levels were analysed in the sorted cells. MEFs 
that were at an early stage of reprogramming expressed similar levels of Nanog 
mRNA to the parental MEF line (p>0.05; Figure 3-18). Nanog expression 
increased as reprogramming progressed to an intermediate stage of 
reprogramming (p<0.001), and further still to late stage reprogramming 
(p<0.001; Figure 3-18). MEFs that expressed Oct4 had a similar level of Nanog 
expression as an iPS line (p>0.05), but lower than a mES line (p<0.01; Figure 
3-18).
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F igu re  3-17: S o rtin g  cells in to  d iffe ren t stages of rep ro g ram m in g
Oct4-GFP MEFs transduced with fSV2A sorted on day 18 into three stages of 
reprogramming based on the gates shown (purple): early (SSEAl" Oct4”), 
intermediate (SSEA1+ Oct4") and late (SSEA1+ Oct4+). Representative of two 
independent experiments.
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F igure  3-18: N anog expression  in creases  d u rin g  rep ro g ram m in g
qPCR for Nanog normalised to Gapdh (mean ± SE of technical triplicate repeats) 
in untransduced MEFs (day -2), early, intermediate and late stage day 18 MEFs 
(see Figure 3-17), mES and iPS cells. Analysed using ANOVA with Bonferroni 
adjustment: p>0.05 (NS); p<0.05 (*); p<0.01 (**); p<0.001 (***). Representative 
of two independent experiments.
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In contrast, Id l transcript levels decreased as reprogramming progressed 
(p<0.001; Figure 3-19). The lowest Id l transcript levels were observed in cells 
with pluripotent characteristics (p<0.001; Figure 3-19). In contrast to Nanog, no 
difference in Id l transcript levels was observed between late stage 
reprogramming MEFs, mES cells and an iPS line (p>0.05; Figure 3-19).
Id3 transcript levels also decreased as reprogramming progressed (p<0.001; 
Figure 3-20). The lowest IdS transcript levels were again observed in cells with 
pluripotent characteristics (p<0.001), with no difference observed between cells 
in late stage reprogramming, mES cells and an iPS line (p>0.05; Figure 3-20). 
However, in contrast to Id l, IdS mRNA levels were 3.IX higher in early stage 
reprogramming compared to the parental line (p<0.001; Figure 3-20), suggesting 
that Ids may be induces as cells initiate reprogramming, but after the 48h 
period examined earlier (Figure 3-16).
Interestingly, the decrease in Id l transcript observed in the later stages of 
reprogramming was not accompanied by a loss of Id l protein. The highest Id l 
protein levels were observed in mES and IPS cells - those with the lowest 
transcript levels (Figure 3-21). Unfortunately, due to the small number of cells 
obtained from the sort (Figure 3-17), only enough lysate was available to assay 
Id l protein levels, and not IdS, by western blot. These data provide evidence 
that both Id l and IdS are transcriptionally down-regulated during 
reprogramming. However, at least in the case of Id l, this decrease in transcript 
does not result in decreased protein expression. Taken together, these data 
suggest that Id l might be post-transcriptionally regulated.
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F igure  3-19: C hanges in  Id l  mRNA expression  d u rin g  rep ro g ram m in g
qPCR for Nanog normalised to Gapdh (mean ± SE of technical triplicate repeats) 
in the samples described and analysed above (Figure 3-18): untransduced MEFs 
(day -2), early, intermediate and late stage day 18 MEFs, mES and iPS cells. 
Analysed using ANOVA with Bonferroni adjustment: p>0.05 (NS); 
p<0.001 (***). Representative of two independent experiments.
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F igure  3-20: C hanges in  Id3 mRNA expression  d u rin g  rep ro g ram m in g
qPCR for Nanog normalised to Gapdh (mean ± SE of technical triplicate repeats) 
in the samples described and analysed above (Figure 3-18): untransduced MEFs 
(day -2), early, intermediate and late stage day 18 MEFs, mES and iPS cells. 
Analysed using ANOVA with Bonferroni adjustment: p>0.05 (NS); p<0.001 
(***). Representative of two independent experiments.
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F igure  3-21: C hanges in  Id l  p ro te in  levels d u rin g  rep ro g ram m in g
Western blot for Id l and Tubulin in the cells described and analysed above 
(Figure 3-18): untransduced MEFs (day -2), early, intermediate and late stage 
MEFs sorted on day 18, mES and iPS cells.
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3-4 Post-transcriptional regulation of Id l
Analysis of changes in Id l mRNA and protein levels during reprogramming 
suggested that the two were inversely correlated. Interestingly, another 
disparity was apparent from the experiments described above: MEFs in an early 
stage of reprogramming had modestly lower levels of Id l transcript than their 
parental MEF line (0.69X; p<0.001; Figure 3-19), but this small change in 
transcript was accompanied by a large decrease in protein levels Figure 3-21).
Whereas it unclear what the exact nature of these “early stage” MEFs were, 
they were likely to represent a population of non-proliferative cells, either 
caused by contact inhibition (Nilausen & Green, 1965) or senescence induced by 
four factor expression (Banito et ah, 2009). Since Id l expression is low in non­
proliferating cells (Alani et ah, 2001), this hypothesis would be consistent with 
the experimental data (Figure 3-21). Taken together, these observations led to a 
series of experiments focused on the post-transcriptional regulation of Id l in 
MEFs undergoing senescence.
3-4-1 Changes in Id l expression during senescence
A classical in vitro model for cellular senescence involves the culture of cells for 
a prolonged period of time (Hayflick & Moorhead, 1961). WT MEFs were derived 
and over the course of six passages, the MEFs changed morphology (Figure 
3-22) and decreased their rate of proliferation (Figure 3-23). At each passage, 
samples were taken for protein and RNA analysis.
94
P a ssa g e  1
%'à
:V -,
Ù l M  ' #
% î /
P a ssa g e  6
'' %' ‘.V
«  V
Figure 3-22: Change in morphology as MEFs undergo senescence
Representative lOX phase contrast microscopy images of early passage and late 
passage MEFs. Representative of more than three independent experiments.
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Figure 3-23: Growth curve of MEFs over the course of six passages
MEFs were maintained at sub-confluence and counted prior to plating at each 
passage. Shown is the projected total number of cells if all cells were plated at 
each passage. Representative of two independent experiments.
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Protein expression was measured by western blot and quantified. To confirm 
that these cells were indeed undergoing senescence, expression of the 
senescence regulator p i w a s  measured. Levels of p i i n c r e a s e d  
dramatically over the six passages (0.02X— l.OOX; Figure 3-24). Levels of Id l 
protein decreased as cells underwent senescence (l.OOX -  0.83X; Figure 3-24).
However, this decrease in Id l protein expression was not accompanied by a 
decrease in mRNA expression: in late passage MEFs where Id l protein levels 
were lowest, transcript levels had increased 2.28X compared to P I MEFs 
(p<0.001; Figure 3-25). Overall, this demonstrated that the loss of Id l protein 
that occurs as primary MEFs undergo senescence was not accompanied by a loss 
of transcript.
It was recently noted that human osteosarcoma cell lines expressed Id2 protein 
at markedly different levels and yet had similar levels of ID2 (the human 
orthologue of mouse Id2) transcript (Williams et al., 2011). These differences 
were attributed to expression of a deubiquitinating enzyme USPl, and its 
cofactor WDR48, which removed a ubiquitin modification on Id family members, 
preventing their proteasomal degradation (Williams et al., 2011). To test the 
hypothesis that increased proteasomal degradation of Id l occurred as 
senescence progressed, the proteasomal inhibitor MG 132 was used.
MEF, p a s s a g e
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Figure 3-24: Id l expression as MEFs senesce
WT MEFs were maintained until passage limit. A: Western blot for Id l, p i6^^^  ^
and Tubulin expression. The Id l doublet was observed at -15 kDa, separated by 
-600 Da. B: Quantification of Id l (doublet) and plG^^^^A protein levels, 
normalised to Tubulin. Representative of two independent experiments.
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F igure  3-25: Id l  mRNA levels as M EFs senesce
qPCR for Id l normalised to Gapdh (mean ± SE of technical triplicate repeats) in 
the MEFs described above (Figure 3-24). Analysed using ANOVA with 
Dunnett’s post-test, relative to passage 1: p<0.001 (***). Representative of two 
independent experiments.
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3-4-2 P ro teaso m al in h ib itio n  in  MEF u n d erg o in g  senescence 
MG132 has been used to block proteasomal degradation of Id l at a range of 
concentrations and for different time periods (Trausch-Azar et al., 2004;
Williams et al., 2011). Initially, MEFs were treated with lOpM and 20|xM for 
15min — 120min before lysis. To ensure accurate incubation times, cells were 
lysed directly in wells by scrapping in lysis buffer. Id l protein readily 
accumulated as incubation time increased, though no further accumulation was 
observed >60min (Figure 3-26). Furthermore, no clear difference was observed 
between lOpM and 20pM pre-treated cells (Figure 3-26).
Based on these results, MEFs were pre-treated at each passage at lOjiM MG132 
for 60min. As MEFs progressed through senescence, Id l protein levels decreased 
(Figure 3-27), as previously above (Figure 3-24). Whereas proteasomal inhibition 
readily resulted in accumulation of Id l protein in early passage MEFs, no Id l 
protein accumulated in late passage MEFs following MG132 pre-treatment 
(Figure 3-27), suggesting the protein was not being actively translated.
Taken together, these results suggested that the disparity between Id l protein 
and transcript observed as MEFs progressed towards senescence may be 
mediated at post-transcriptional level, potentially by the binding of miRNAs to 
the 3’ UTR of transcripts (Filipowicz et al., 2008).
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F igure  3-26: O ptim isation  of MG132 p re -trea tm en t
Western blot for Id l and Tubulin in early passage MEFs. Prior to lysis, MEFs 
were treated with MG132 at the concentrations and times shown.
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F igure  3-27: P ro teasom al in h ib itio n  in  MEFs u n d ergo ing  senescence
Western blot for Id l and Tubulin in MEFs of passage (P)l-5. MEFs were 
pre-treated with lOpM MG-132 or vehicle control (0.1% DMSG) for 60min prior 
to lysis. The last three lanes show a slight shift in the Tubulin band, which was 
due to a small tear in the gel, which occurred prior to transfer; otherwise 
representative of two independent experiments.
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3-5 Role of the Id l 3’ UTR in gene expression regulation
The 8’ UTRs of the mouse Id family members were cloned into the psiCHECK2 
vector downstream of the Renilla luciferase coding region (see “2-3-2 Cloning 3’ 
UTRs into psiCHECK2”). Luciferase activity (calculated as a ratio of 
RenillaiFiYefly) was measured in early passage MEFs 24h after transfection of 
psiCHECK2 with these 3’ UTRs or a no 3’ UTR control. No repression by the Id2 
or Id4 3’ UTR was observed in MEFs, compared to the no 3’ UTR control 
(p>0.05; Figure 3-28). However, luciferase activity decreased in the presence of 
the Id l 3’ UTR (0.45X, p<0.01) and Id3 (0.75X, p<0.01) compared to the no 
3’UTR (Figure 3-28). These data suggested that Id l might be repressed by its 
3’ UTR in early passage MEFs. However, it was unclear how repression by this 
3’ UTR changed as MEFs transitioned towards senescence.
3-5-1 How is the Id l 3’ UTR regulated during senescence?
Initially, early (P2) and late passage (P5) MEFs were plated at the same density 
and transfected with psiCHECK2 with no 3’ UTR. Luciferase activity was 
measured in these MEFs after 24h. Compared to P2 MEFs, activity was greatly 
reduced in P5 MEFs for both Firefly (0.07X; p<0.001) and Renilla (0.05X; 
p<0.05) luciferase. Furthermore, luciferase activity in P5 MEFs was 
indistinguishable from the background activity observed in untransfected MEFs 
(p>0.05; Figure 3-29). Since psiCHECK2 could not be used to assay repression 
by 3’ UTRs in late passage MEFs, an alternative strategy was used.
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F igu re  3-28: R epression  by th e  3’ UTR of Id  fam ily m em bers
L uciferase  ac tiv ity  w as m ea su red  in  ea rly  p a ssag e  M E Fs 24h a fte r  tra n s fe c tio n  
of psiC H E C K 2 w ith  no 3’ U TR or th e  3’ U T R s of Id  fam ily  m em bers ( Id l  -  Id4). 
L uc ife rase  ac tiv ity  (m ean  ± SE of biological tr ip lica te ) is exp ressed  as  a  ra tio  of 
ReniZ/a:Firefly luciferase , n o rm alised  to psiC H E C K 2 w ith  no 3’ UTR. A na ly sed  
u s in g  ANOVA w ith  D u n n e tt’s p o st-tes t, re la tiv e  to  no 3’ UTR: p<0.01 (**); 
p<0.001 (***). R e p re sen ta tiv e  of th re e  in d ep e n d e n t ex p erim en ts .
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F igu re  3-29: psiCHECK2 in  early  an d  la te  passage MEFs
P2 and P5 MEFs were transfected with psiCHECK2, Firefly and Renilla 
luciferase activity (mean ± SE of biological triplicate) was measured after 24h. 
Analysed using ANOVA with Bonferroni adjustment: p>0.05 (NS); p<0.05 (*); 
p<0,001 (***). Representative of two independent experiments.
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The lentiviral vector Bd.LV has a bi-directional promoter driving expression of 
GFP and mCherry (see “2-3-3 Cloning 3’ UTRs into Bd.LV”). The Id l 3’ UTR was 
cloned into this vector downstream of GFP. Transduced MEFs were maintained 
in culture and at each passage, and a small aliquot of cells was analysed by flow 
cytometry to measure GFP and mCherry levels. The ratio of GFP:mCherry 
expression was calculated using Flow Jo and normalised to the no 3’ UTR 
control.
Over time, the ratio of GFP:mCherry expression decreased from P2 to P5 (0.33X; 
p<0.001; Figure 3-30), suggesting that repression of the Id l 3’ UTR increased as 
cells underwent senescence. However, the mechanism of this repression was 
unclear.
A common mechanism of repression by the 3’ UTR of transcripts is miRNAs; 
short, non-coding RNAs that bind via sequence complementarity to induce 
transcript degradation or translational repression. Therefore, the design of 
truncation mutants of the 3’ UTR was initially based on the hypothesis that 
miRNAs regulate the Id l 3’ UTR.
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F igu re  3-30; R epression  of th e  Id l  3’ UTR d u rin g  senescence
MEFs transduced with Bd.LV (see Materials and Methods) with either no 3’ UTR 
or the Id l 3’ UTR downstream of GFP were analysed at passage 2, 4 and 5 for GFP 
and mCherry expression by flow cytometry. The calculated GFP:mCherry ratio 
(mean ± SE) of the Id l 3’ UTR construct, normalised to no 3’ UTR, is shown. 
Representative of two independent experiments.
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3-5-2 What region of the Id l 3’ UTR is required for repression?
TargetScan (Lewis et al., 2003) is a computation tool for the prediction of 
miRNA binding sites: three sites were predicted in the Id l 3’ UTR. Truncation 
mutants of the Id l 3’ UTR were cloned into psiCHECK2, whereby each 
truncation removed another predicted binding site (Figure 3-3lA), and 
constructs transfected into early passage MEFs. Truncation of the predicted 
miRNA binding site furthest from the coding region of mouse Id l (removal of 
bases 367-397; Tl) did not alter luciferase activity compared to WT Id l 3’ UTR 
(p>0.05). Truncation of the second (removal of bases 303-397; T2) or third 
(removal of bases 182-397; T3) miRNA binding site resulted in luciferase 
activity that was similar to the control psiCHECK2 vector with no 3’ UTR levels 
(p>0.05; Figure 3-31B). This data suggested that bases 303-366 of the mouse Id l 
3’ UTR contained a regulatory element.
Since one predicted miRNA binding site was present in this region, the full- 
length Id l 3’ UTR was cloned into psiCHECK2 in which either a single base 
(Ml) or three bases (M3) in this miRNA binding site had been modified (Figure 
3-32A). Both mutations of this site resulted in complete recovery to no 3’ UTR 
levels (p>0.05) compared to the WT Id l 3’ UTR (Figure 3-32B). Based on seed 
sequence complementarity, this predicted binding site was targeted by miR-381 
and miR-539-3p (Lewis et al., 2005).
Taken together these data suggested that miR-381 and/or miR-539-3p might 
regulate Id l via its 3’ UTR and so a variety of tools to modulate activity of these 
miRNAs were used.
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F igure  3-31: T ru n ca tio n  m u tan ts  of th e  Id l  3’ UTR
A: WT and truncated (T1-T3) Id l 3’ UTRs, with TargetScan predicted miRNA 
binding sites (orange) and length in bases (b). B: Luciferase activity (mean ± SE 
of biological triplicate) of early passage MEFs 24h after transfection of 
psiCHECK2 with no 3’ UTR, WT or Tl-3 Id l 3’ UTRs. Analysed using ANOVA 
with Dunnett’s post-test relative to the no 3’UTR control: p<0.001 (***). 
Representative of three independent experiments.
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F igure  3-32: P o in t m u ta tio n s  of th e  Id l  3’ UTR
A: The Id l 3’ UTR (WT) with either one (Ml) or three (M3) point mutations (red) 
in the second predicted miRNA binding site (orange). B: Luciferase activity 
(mean ± SE of biological triplicate) of early passage MEFs 24h after transfection 
of psiCHECK2 with no 3’ UTR, WT or m utant Id l 3’ UTRs. Analysed using 
ANOVA with Dunnett’s post-test relative to the no 3’UTR control.
Representative of three independent experiments.
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3-5-3 Does altering specific miRNA activity affect Id l regulation?
Early passage MEFs were transfected in suspension with mimics for miR-381 
and miR-539-3p. After 2h, the cells had adhered and were transfected with 
psiCHECK2. Luciferase activity was measured after 24h and as previously 
observed, the Id l 3’ UTR was under repression (0.35X; p<0.001; Figure 3-33). 
However, transfection with mimics for miR-381 or miR-539-3p did not further 
repress the Id l 3’ UTR (p>0.05; Figure 3-33).
Since the Id l 3’ UTR is already under repression, even in early passage MEFs 
(Figure 3-28), further repression by mimics of miRNAs may be modest and 
difficult to detect. Therefore, attempts were made to inhibit miR-381 or 
miR-539-3p activating using locked nucleic acids (LNA)s and sponges (see “2-2-4 
Transfection of synthetic miRNA regulators” and “2-3-4 Cloning miRNA sponges 
into pTripZ”).
LNAs are stable, synthetic antisense RNAs that bind to, and inhibit the activity 
of endogenous miRNAs. Early passage MEFs in suspension were transfected 
with LNAs designed to inhibit miR-381, miR-539-3p and a non-inhibiting 
control. After 2h, the adherent cells were transfected with psiCHECK. Since the 
action of LNAs is not direct, luciferase activity was measured 72h after 
transfection to permit LNA:miRNA interaction. Again, as previously observed, 
the Id l 3’ UTR was under repression (0.44X; p<0.001; Figure 3-34). However, 
transfection with LNAs against miR-381 or miR-539-3p did not relieve 
repression by the Id l 3’ UTR (p>0.05; Figure 3-34).
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F igure  3-33: U sing miRNA m im ics to m odu la te  th e  Id l  3 UTR
Luciferase activity (mean ± SE of biological triplicate) in early passage MEFs 
24h after transfection with psiCHECK2 (no or Id l 3’ UTR) and mimics of miR- 
381, miR-539-p or a non-silencing control (Ctrl). Analysed using ANOVA with 
Bonferroni adjustment: p>0.05 (NS); p<0.001 (***). Representative of two 
independent experiments.
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F igure 3-34: U sing LNAs to in h ib it miRNA activ ity
Luciferase activity (mean ± SE of biological triplicate) in early passage MEFs 
72h after transfection with psiCHECK2 (no or Id l 3’ UTR) and LNAs that 
inhibit miR-381, miR-539-3p or a non-inhibiting control (Ctrl). Analysed using 
ANOVA with Bonferroni adjustment: p>0.05 (NS); p<0.001 (***). 
Representative of two independent experiments.
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Sponges are transcripts tha t contain miRNA recognition sites and attenuate 
repression of endogenous targets of specific miRNAs (Ebert & Sharp, 2010). 
Sponges against miR-381, miR-539-3p and a scrambled control were designed 
and cloned (see Materials and Methods) downstream of a doxycycline inducible 
turboRFP coding region in a lentiviral vector. These transcripts comprised of six 
repeats of a sequence with complementarity to both ends of a target miRNA, 
with three non-complementarity bases in the central region designed to form a 
bulge upon miRNA binding. A sponge against both miR-381 and miR-539-3p 
contained six complementary sequences, three repeats against each miRNA.
MEFs were transduced and selected using puromycin for 36h. MEFs were 
treated with or without doxycycline for 6d. During this time, expression of 
turboRFP was readily observed by fluorescence microscopy in cells treated with 
doxycycline (Figure 3-35). Id l protein levels were measured by western blot, and 
did not change in response to sponge expression against miR-381, miR-539-3p or 
both (Figure 3-36).
Taken together, these data do not support a hypothesis by which the Id l 3’ UTR 
is regulated by miR-381 or miR-539-3p. Since attempts to manipulate the 
activity of these miRNAs had no affect on 3’ UTR regulation or Id l expression, 
tools were generated to mutate the endogenous 3’ UTR in somatic cells to 
further probe this mechanism of repression.
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F igure  3-35: E xpression  of tu rb o R F P  in MEFs tra n sd u c e d  w itb  sponges
Representative lOX phase contrast fluorescent microscopy images of turboRFP 
expression in MEFs. MEFs had been transduced with an inducible sponge 
against miR-381 and treated with Opg/ml or 2.5|ig/ml doxycycline for 24h. 
Representative of two independent experiments.
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Figure 3-36: Effect of sponges on Id l expression
Western blot for Id l and Tubulin in MEFs that were transduced with 
doxycycline inducible sponges against miR-381, miR-539, both miR-381 and 
miR-539 (Both) or a scrambled sponge (Scr). Cells were lysed after treatm ent 
with doxycycline for 6d.
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3-5-4 M utating the endogenous Id l 3’ UTR.
Manipulation of miR-381 or miR-539-3p activity did not alter regulation by the 
Id l 3’ UTR or Id l protein levels, so the mechanism of repression remained 
unclear. Furthermore, it was unclear whether the observed repression by the 
Id l 3’ UTR occurred endogenously or was an artefact of the reporter system. 
Therefore, tools were generated to mutate the endogenous site which encodes 
the conserved regulatory region of the Id l 3’ UTR.
Transcription activator like effect nucleases (TALENs) are synthetic restriction 
enzymes that can be designed to introduce double strand breaks (DSBs) in DNA. 
DSBs may be repaired by non-homlogous end-joining (NHEJ), which is prone to 
insertion or deletion of bases (Aniukwu et al., 2008). TALENs bind in pairs, 
upstream and downstream of the target site, resulting in dimérisation of the 
FokI nuclease and thus DSB. Two pairs of TALENs were designed and 
generated to introduce mutations within the predicted miR-381 / miR-539-3p 
binding site of the Id l 3’ UTR (see Materials and Methods).
TALENs were tested by using the reporter system of Certo et al. (2011) with a 
50bp fragment of the Id l 3’ UTR coding region cloned into the non-functional 
GFP coding region. MEFs, transduced with the lentiviral reporter vector, were 
transfected with either empty vector, or a pair of TALENs. 16h after 
transfection, the medium was changed and cells transferred to 30°C for 72h.
This protocol enhances cleavage by zinc finger nucleases (Doyon et al., 2010) and 
TALENs (Carlson et al., 2012). Cells were subsequently returned to 37°C. Cells 
were analysed for mCherry expression by flow cytometry 9d after transfection.
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Whereas some cells that had been transfected with empty vectors were mCherry 
positive (0.5%), a greater number of mCherry positive cells were observed in 
those transfected with pair 1 (2.1%) or pair 2 (1.0%) (Figure 3-37).
This data suggested that the TALEN pairs generated can introduce mutations 
at an exogenous Id l 3’ UTR fragment and that in the case of MEFs, pair 1 may 
do so at greater efficiency. These TALENs could therefore be used to introduce 
mutations in a wide range of cells.
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F igure  3-37: M easuring  efficiency of TALENs
mCherry expression in MEFs measured by flow cytometry 9d after transfection 
with TALENs (pair 1 or pair 2) or empty vector. MEFs expressed a reporter for 
DSB repair at an exogenous Id l 3’ UTR fragment that would express mCherry in 
~33% of NHEJ events. Representative of two independent experiments.
119
Ch a pt e r  4: D is c u ssio n
One challenge of studying mES cells in vitro is ensuring that they maintain 
their pluripotent status in culture. Successful explantation of mES cells from 
the blastocyst initially relied on their culture on a feeder monolayer in medium 
with serum (Evans & Kaufman, 1981; Martin, 1981). Ying et al. (2003a) 
demonstrated that pluripotent mES could be maintained on gelatin in serum- 
free medium supplemented with LIE and BMP4, the latter acting to induce Id 
family members. Furthermore, ectopic expression of Id l was sufficient to replace 
the requirement for BMP4 (Ying et al., 2003a).
4-1 The role o f Id l in pluripotency
Subsequent work demonstrated that Id l expression is required for the 
maintenance of pluripotency in vitro (R-omero-Lanman et al., 2012), though the 
precise mechanism for the deficiency in pluripotency observed in mES 
remained unclear. Romero (2009) noted that mES cells express lower levels 
of the pluripotency regulator Nanog, and suggested that this was due to 
elevated Zebl expression (Figure 1-7).
4-1-1 Re-evaluating the regulation o f Nanog by Id l
Zebl was initially identified as a regulator of the Rattus norvégiens gene A tp la l  
(Watanabe et al., 1993). Zebl has two zinc finger clusters at the N- and C- 
terminal regions which are responsible for DNA binding to the consensus 
sequence CACCT(G) (Genetta et al., 1994; Ikeda & Kawakami, 1995). The 
related E-box binding protein Zeb2 was identified in a two-hybrid yeast screen 
for SMAD binding partners (Verschueren et al., 1999) and also binds to the
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consensus sequence CACCT(G) (Postigo & Dean, 2000). Transcriptional 
repression occurs via binding of Zebl or Zeb2 to the promoter of a target gene 
with its co-repressor CtBP-1 (Postigo & Dean, 1999; Postigo & Dean, 2000).
The antibody previously used to characterise Zebl expression in mES cells 
(Figure 1-7) was raised using an epitope that had 100% identity between mouse 
Zebl and Zeb2 (Figure 3-2). Whereas Zebl mRNA levels were not higher in 
mES cells, Zeb2 mRNA increased >20 fold (Figure 3-1). Taken together, this 
raised doubts over the specificity of this antibody for Zebl. Since aspecific 
binding of antibodies to related family members can result in misinterpretation 
of data (Perk et al., 2006), it was important to test the affinity of this antibody 
for Zebl.
Cell lines deficient for either Zebl or Zeb2 would be useful for antibody testing 
and could be generated (Higashi et al., 2002; Takagi et al., 1998). However, since 
these lines were not immediately available, 293T cells that transiently and 
ectopically expressed mouse Zebl and Zeb2 were generated. Protein expression 
in these 293T cells and mES cells was measured by western blot with the Zebl 
antibody (1) used by Romero (2009). Whereas a band was observed at ~75 kDa at 
greater intensity in IdV^' cells, this band was not observed in 293T cells 
expressing either Zebl or Zeb2 (Figure 3-3), suggesting that this antibody did 
not bind to either protein.
In contrast, when using Zebl antibody 11 to probe a duplicate membrane, a 
single band was observed in 293T cells expressing Zebl, but not Zeb2 at 
~100kDa (Figure 3-4), similar to the predicted molecular weight of
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~122kDa (Wilkins et al., 1999). A corresponding band was observed in WT and 
Idr^' mES cells at equal intensities (Figure 3-4). Taken together with the modest 
change in Zebl transcript levels, these data do not suggest that Id l regulates 
Zebl expression.
The elevated Zeb2 transcript levels observed in Idl''' mES cells (Figure 3-1) 
suggested the Zeb2 protein levels may be elevated. Unfortunately, attempts to 
characterise Zeb2 expression in mES cells was unsuccessful (Figure 3-5), though 
this may be achieved with the use of other antibodies. Since Zebl and Zeb2 bind 
to the same consensus sequences (Postigo & Dean, 2000), Zeb2 may be capable 
of repressing the Nanog promoter in a similar manner to Zebl (Figure 1-7B). 
This hypothesis would be consistent with the observation that Zeb2 is repressed 
during reprogramming and is low in pluripotent cells (Mikkelsen et al., 2008).
Future experiments could use ectopic expression of Zeb2 in mES cells to observe 
repression of pluripotency, with respect to Nanog expression and promoter 
activity. However, the retroviral silencing observed in pluripotent lines 
(Maherali et al., 2008) may preclude the use of the vector pBabe-Zeb2 described 
here. If Zeb2 was capable of regulating Nanog expression, knockdown of Zeb2 in 
Idl'^' mES cells may relieve repression and thus rescue the pluripotency defect 
in these cells.
In contrast to previous data (Figure 1-7), the present data does not support a 
model whereby Id l inhibits Zebl expression to maintain Nanog expression in 
mES cells. Whereas ablation of Id l does not impair embryogenesis, IdT^' mES 
cells have a defect in maintaining pluripotency in vitro, presumably because
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pluripotent cells persist during embryogenesis for much shorter periods of time. 
The focus of the present work therefore shifted towards understanding the role 
of Id l in iPS cell reprogramming, an in vitro system in which cells acquire 
pluripotent characteristics.
4-1-2 Idl or Ids deficiency in MEFs impairs feeder free reprogramming
A range of techniques have been used to introduce ectopic expression of factors 
for reprogramming somatic cells, including retroviral (Takahashi & Yamanaka, 
2006; Wernig et a l, 2007), lentiviral (Carey et ah, 2009; Maherali et al., 2008) 
and adenoviral (Stadtfeld et al., 2008c) vectors. Initially, nucleofection was used 
to introduce the four factors into MEFs, using linearised pCAG2LMKOSimO. 
Whereas an iPS line generated phenocopied mES cells in terms of morphology 
(Figure 3-8), AP staining (Figure 3-9), Nanog expression was lower than mES 
cells at both the transcript (Figure 3-18) and protein (Figure 3-10), indicating 
incomplete reprogramming. More stringent characterisation of this and other 
iPS lines would be required to assess reprogramming status, and might include 
teratoma formation and contribution to chimeric mice (Wernig et al., 2007).
There were two major disadvantages to nucleofection. Firstly, the percentage of 
cells expressing the four factors was extremely low; less than 7% were mOrange 
positive (Figure 3-6), leading to a very low percentage of cells initiating 
reprogramming. Secondly, nucleofection induces a senescent phenotype in IdV^' 
MEFs (Figure 3-11), precluding the use of this technique to compare 
reprogramming efficiency between Id l deficient and WT lines.
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Therefore, fSV2A a single lentiviral vector encoding the four factors (Papapetrou 
& Sadelain, 2011) was used, since this permitted the reprogramming of Id 
deficient MEFs.
Since the role of Id l in maintaining pluripotency in vitro was relatively well 
established (Romero-Lanman et al., 2012), the requirement of Id l, and its 
closest related family member ld3, for the initiation of reprogramming was 
initially tested. WT, and IdS'^' MEFs were derived from separate litters a 
transduced with fSV2A. After lOd, cells were stained for elevated AP activity, an 
early marker of reprogramming (Brambrink et al., 2008). Both Idl'^' and Id3'^' 
MEFs had a severe defect in the initiation of reprogramming (Figure 3-12).
Idr^' MEFs do express higher levels of the senescence mediator p i ( A l a n i  
et al., 2001) and senesce in response to nucleofection (Figure 3-11). Expression of 
the four factors does induce senescence in MEFs via elevated levels of p53, 
pl6iNK4A p21^i^^ (Banito et al., 2009). Furthermore, inhibiting these 
senescence pathways improves reprogramming efficiency (Banito et al., 2009). 
The deficiency in Idl'^' may therefore due to elevated senescence mediators. 
However, this does not explain a similar deficiency observed in Id3'^' MEFs and 
must suggest a novel role for ld3 in mediating senescence.
Certainly analysis of the expression of senescence mediators in Id3'^' would be 
worth exploring. Furthermore, staining for senescence associated P- 
galactosidase (Debacq-Chainiaux et al., 2009) in WT and Id deficient MEFs 
following reprogramming could be used to see if indeed the defect in 
reprogramming is due to increased senescence. Cell cycle analysis should be
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carried out on WT and Id deficient MEFs expressing fSV2A, as this may reveal 
proliferation defects that decrease the efficiency of reprogramming.
Since these MEF were reprogrammed on gelatin, cells that do not undergo 
reprogramming can act as feeder cells (Choi et al., 2011). Furthermore, MEFs of 
different genotypes were derived from separate crosses and were therefore 
unrelated. It was therefore unclear whether the observed defect in 
reprogramming was due to genetic differences between target cells or 
differences in their role as feeder cells. To control for these possibilities, WT and 
7c?i'^'MEFs were derived from a single litter and reprogrammed for lOd on 
feeder cells. In contrast to previous feeder free reprogramming experiments 
(Figure 3-12), no difference in reprogramming efficiency was observed between 
WT and IdV^' MEFs (Figure 3-13). It remains to be confirmed that these related 
MEFs retain their defect in reprogramming in the absence of feeders.
It was recently demonstrated that ablation of pl6^^^'^ high (i.e. senescent) cells 
in mouse models of aging delayed the onset of degenerative disorders (Baker et 
al., 2011). The results support a hypothesis that the senescent cells that 
accumulate in the tissues of aging organisms inhibit tissue function in a non-cell 
autonomous manner via secreted chemicals. Therefore, the observed deficiency 
in feeder free reprogramming may be related to premature senescence in the 
IdV^' pseudo-feeder cell layer, resulting in the onset of senescence in a non-cell 
autonomous manner via the secretion of senescence mediating factors and thus 
impeding reprogramming (Banito et al., 2009). Future experiments could use 
WT MEFs for reprogramming on WT and IdV^' feeder cells, or medium 
conditioned with these cells, to assess reprogramming status.
125
Since deficiency in Id family members impaired the initiation of reprogramming, 
it was possible that appropriate manipulation of Id expression may improve 
efficiency of reprogramming. Analysis of Id l and ld3 expression during 
reprogramming was carried out to understand how expression changed.
4-2 D isparities betw een Id l protein and mRNA levels
Understanding how Id expression changes during reprogramming would guide 
the manipulation of Id expression via genetically modified alleles to alter the 
efficiency of reprogramming. Inducible changes in the expression of Id family 
members is possible via floxed alleles (Niola et al., 2012) or the inducible 
expression of Id l (Nair et al., 2010).
4-2-1 Id expression in cells undergoing reprogramming
To assess if Id l or ld3 was targeted early in reprogramming, MEFs were 
transduced with lentiviral vectors encoding either one or all four factors. 
Whereas modest changes (0.50X — 2.00X) in Id l or ld3 mRNA levels after 
expression of specific factors were observed 48h after transduction, these 
changes did not alter expression at the protein level (Figure 3-15; Figure 3-16). 
Ectopic expression of single factors by this time is likely, since fluorescent 
proteins linked by self-cleaving 2A peptides were also expressed in these cells 
(Figure 3-14).
Limited evidence suggests that Myc regulates Id l and that its ectopic expression 
is sufficient to drive Id l expression in MCF-7 cells (Swarbrick et al., 2005), 
though this ability may be restricted to specific cellular contexts. Alternatively,
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prolonged expression of MYC may be required to modulate Id l expression. 
Furthermore, since fSV2A does not encode a fluorescent protein, transduction 
efficiency cannot be estimated. Therefore, it is unclear what percentage of the 
population analysed by qPCR and western blot ectopically expressed these four 
factors.
Consistent with the role of Nanog as a pluripotency regulator (Chambers et al., 
2003), expression is very low in MEFs and early stage reprogramming, and 
highest in pluripotent cells and late stage reprogramming (Figure 3-18). In 
keeping with a stepwise model of reprogramming in which the Nanog locus is 
activated before the Oct4 locus (Brambrink et al., 2008), Nanog transcript is 
detected at intermediate levels prior to expression of GFP from the Oct4 locus 
(Figure 3-18). It is certainly possible that both loci become activated at a similar 
time, but tha t there is a delay in fluorescent protein expression and 
accumulation to detectable limits. The use of qPCR for Oct4 and/or GFP 
transcript would clarify the aforementioned model (Brambrink et al., 2008).
Given that Id protein levels tend to be highest in stem cells, it was expected tha t 
transcript would increase as reprogramming progressed. However, Id l and ld3 
mRNA levels decreased during this process and were lowest in pluripotent line 
(Figure 3-19; Figure 3-20). These observations were consistent with published 
microarray data (Mikkelsen et al., 2008) in which expression of cells during 
reprogramming using an SSEAl antibody was compared to MEFs, iPS and ES 
cells.
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However, the loss of Id l transcript was not concomitant with decreased protein 
levels: Id l levels were highest in pluripotent lines or those in the later stages of 
reprogramming (Figure 3-21). When proteins were separated on high percentage 
acrylamide gels (12% or 15%), the Id l band appeared as a doublet migrating at 
-15 and -15.6 kDa (Figure 3-21, Figure 3-25). This doublet has been previously 
observed and thought to be the result of 0-linked glycosylation (Pache et al., 
2006) and may indicate a form of post-translational Id l regulation. Experiments 
using 0-linked glycosylation inhibitors or expression constructs with mutations 
at a putative glycosylation site would help clarify this possibility.
Unfortunately, insufficient material was available for analysis of ld3 protein 
levels. However, analysis of MEFs, mES and iPS cells should be sufficient to 
indicate how levels change of ld3 protein change during reprogramming.
Interestingly, the parental untransduced MEFs had high Id l protein levels 
which contrasted sharply with very low protein levels in MEFs tha t were still at 
an early stage of reprogramming by day 18 (Figure 3-19). This stark difference 
in protein levels was accompanied by only a modest decrease in transcript levels 
(Figure 3-21). These observations led to an analysis of Id l expression as MEFs 
were maintained in vitro.
4-2-2 Id l expression during cellular senescence
Primary MEFs maintained in culture underwent cellular senescence, denoted by 
gross changes in morphology and a decrease in proliferation (Figure 3-22; Figure
3-23). Further characterisation of the senescent phenotype could be carried out 
as described above using senescence associated p-galactosidase staining.
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As cells underwent senescence, Id l protein levels decreased, concomitant with 
an increase in the senescence regulator pl6^^^^^ (Figure 3-24). However, this 
decrease in protein was not accompanied by a decrease in Id l transcript (Figure
3-25). Taken together with the inversely related Id l mRNA and proteins levels 
observed as cells underwent reprogramming (Figure 3-19; Figure 3-21), these 
data suggested that Id l was post-transcriptionally regulated.
Since Id family members are targeted for proteasomal degradation, it is possible 
that at the onset of senescence, Id l is expressed but degraded at higher levels 
than in early passage MEFs. Whereas inhibition of proteasomal degradation 
with MG 132 in early passage MEFs resulted in the accumulation of Id l protein, 
little to no accumulation of Id l was observed in late passage MEFs which were 
undergoing senescence (Figure 3-27). These results indicated tha t Id l was not 
being actively translated in late passage MEFs; this hypothesis could be tested 
using the translational inhibitor actinomycin D in conjuction with MG132. Post- 
transcriptional regulation via the 3’ UTR was subsequently analysed.
4-8 Repression of the Id l 3’ UTR increases during senescence
Disparity between Id l transcript and protein levels could be explained by 
translational repression of the transcript and may be mediated by miRNAs. 
miRNAs were first identified in C. elegans where it was noted tha t mutation of 
the lin-14 3’ UTR resulted in higher levels of lin-14 (Wightman et al., 1991). The 
identification of lin-4, a transcript which regulates lin-14 due to partial sequence 
complementarity to the lin-14 3’ UTR (Lee et al., 1993) occurs via translational 
repression (Olsen & Ambros, 1999; Wightman et al., 1993). Since then, miRNAs
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have been shown to be important in a wide range of physiological and 
pathological processes (He & Hannon, 2004).
Of the four mouse Id family members, only the Id l 3’ UTR was strongly 
repressed in early passage MEFs (0.45X; Figure 3-28). The 3’ UTR of ld3, the 
closest related family member (Figure 1-4B), also exhibited weak repression in 
early passage MEFs (0.75X; Figure 3-28), possibly via a conserved mechanism of 
repression. Furthermore, using a second reporter system, repression of the Id l 
3’ UTR increased during senescence (Figure 3-30).
4-3-1 Identification o f a conserved regulatory region in the 3’ UTR
Numerous algorithms for predicting miRNA binding sites are available, e.g. 
TargetScan (Lewis et ah, 2003), miRanda (Betel et al., 2008) and miRDB (Wang, 
2008), which typically depend on seed sequence complementarity in the 3’ UTR. 
Despite improvements in these algorithms, a high false positive rate persists 
(Leung et al., 2008).
Initially, TargetScan predictions were used to guide the generation of truncation 
mutants of the Id l 3’ UTR, whereby each truncation removed an additional 
predicted miRNA binding sites (Figure 3-31A). Whereas removing the first 
miRNA binding site had no effect on 3’ UTR repression, removing the second 
predicted site relieved repression and suggested tha t a regulatory region existed 
within a 67 base region which contained a single miRNA binding site (Figure
3-31B). Modification of either one or three bases at this single predicted miRNA 
binding site prevented repression by the 3’ UTR (Figure 3-32).
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Interestingly, this site is within a small region that is highly conserved in 
mammals (Figure 4-1). Whereas high levels of sequence conservation are not 
necessarily indicative of a functional role (Ahituv et al., 2007), the stark contrast 
in conservation within this ~50bp region to the remainder of the 3’ UTR 
alongside the reporter data described above led to studies in which the 
hypothesised miRNA activity at this predicted binding site was manipulated.
4-8-2 Modulating miRNA activity
The use of reporter systems suggested tha t the Id l 3’ UTR was under repression 
in early passage MEFs (Figure 3-28) and that this repression increased as these 
cells underwent senescence (Figure 3-30). Whereas mutation of a predicted 
miRNA binding site did relieve repression by the 3’ UTR (Figure 3-32B), it 
remained to be seen if Id l was actually regulated by miRNAs.
A number of synthetic RNA molecules can be used to either mimic or block 
specific miRNA activity. Initially, miRNA mimics that phenocopied increased 
expression of miR-381 or miR-539-3p were transfected into MEFs with the 
reporter vector psiCHECK2. No further repression by the 3’ UTR was observed 
(Figure 3-33), though since repression of the Id l 3’ UTR was already high, it is 
possible that maximum repression had been reached.
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Figure 4-1; Conservation of the regulatory region in the Id l 3’ UTR
Alignment of the Idl 3’ UTR from 20 mammals. Consensus indicated by colour:
2-14 species (yellow), 15-18 species (orange), 19-20 species (red). TargetScan 
predicted three miRNA binding sites (black squares) shown above consensus 
plot. Sequence of the highly conserved region is shown, with the predicted miR- 
381 / miR-539-3p binding site highlighted (green).
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An alternative approach is to block specific miRNA activity. Two approaches 
were used, LNAs and sponges. No relief in the repression by the 3’ UTR was 
observed using LNAs against miR-381 or miR-539-3p (Figure 3-34). 
Furthermore, no increase in Id l protein was observed when doxycycline 
inducible expression of sponges was used (Figure 3-36).
Certain controls would be useful to assess the function of these LNAs and 
sponges. Fluorescently labelled LNAs are available, which could be used to 
confirm that the transfection protocol was suitable for the introduction of these 
molecules into a high percentage of target MEFs. Furthermore, to confirm that 
the endogenous miR-381 or miR-539-3p activity was modulated following LNA 
transfection or sponge expression, a psiCHECK2 plasmid with binding sites for 
these miRNAs downstream of the Renilla locus could be used.
Recently it was reported that the human Id l (IDl) 3’ UTR is regulated by 
miR-29 (Rothschild et al., 2012a) and miR-381 (Rothschild et al., 2012b) in 
adenocarcinoma. Mutation of three bases in the predicted miR-29 binding site 
does relieve repression of the ID l 3’ UTR in a reporter assay (Rothschild et al., 
2012a). However, the miR-29 binding site is not conserved in the mouse Id l 
3’ UTR and is therefore unlikely to be involved in the regulation of Id l 
presented here.
Published evidence for regulation of Id l by miR-381 is largely correlative; levels 
of the miRNA are inversely related to Id l protein levels in human 
adenocarcinoma cell lines following inhibition of Src (Rothschild et al., 2012b). 
Whereas Id l levels decrease upon lentiviral transduction with a miR-381
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precursor, direct regulation of the ID l 3’ UTR by miR-381 is not shown 
(Rothschild et al., 2012b). Taken together with the present work, it is still 
unclear as to how the Id l 3’ UTR is regulated.
Whereas future optimisation of mimics, LNAs and sponges may clearly 
demonstrate regulation of the Id l 3’ UTR by miRNAs, other regulatory 
mechanisms may mediate repression. The neuronal Drosophila gene elav 
encodes an RNA binding protein (RBP) with three recognition motifs (Toba & 
White, 2008). The human elav related RBP Hel-Nl is also restricted to neurons 
and binds to the ID l 3’ UTR (King et al., 1994). Another elav related 
mammalian protein HuR is ubiquitously expressed and binds to adenylate- 
uridylate-rich elements in the 3’ UTRs of regulated transcripts (Fan & Steitz, 
1998). Future experiments could manipulate e/au-related RBPs to see if they can 
regulate Id l via the 3’ UTR.
Since all evidence for repression of the Id l 3’ UTR came from reporter systems 
and because a precise mechanism for repression remained unclear, tools were 
constructed to generate cell lines with mutations in the conserved regulatory 
region of the 3’ UTR.
4-4 Generating tools to m utate the endogenous Id l 3’ UTR
The introduction of mutations via TALENs was chosen (Cermak et al., 2011), 
since it allows much faster introduction of targeted somatic mutations than 
alternative approaches (Rago et al., 2007).
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TALEN pairs were designed to introduce DSBs in the endogenous Id l 3’ UTR at 
the predicted miR-381 / miR-539-3p binding site. These were transfected into a 
MEF line with a reporter that would express mCherry in -33% of NHEJ events. 
Whereas a small percentage of cells transfected with empty vector expressed 
mCherry (0.5%), an increased number of cells transfected with TALEN pair 1 
(2.1%) or pair 2 (1.0%) expressed mCherry and at greater intensity (Figure
3-37).
It is unclear why there is a large difference in efficiency between these TALEN 
pairs. It is certainly possible that the modest differences in the coding region 
affect expression levels of the TALENs. Furthermore, one or both TALENs in 
pair 2 may have increased off-target binding, reducing cleavage at the target 
site.
An alternative to the stochastic mutational approach employing NHEJ would be 
to use homologous recombination (HR; Figure 4-2), compatible with the TALEN 
system and the reporter line (Certo et al., 2011) used in the present work. 
Measuring efficiency of HR using the reporter system is carried out by 
co-transfecting a donor plasmid that encodes a non-functional GFP truncation
with the TALENs. Endogenous HR machinery uses this donor plasmid 
to repair the DSB in ts^GFP, leading to GFP expression (Figure 4-2).
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Out of frame (t)
* g^aCFP T2A? mCherry^
X  X
Q p p tru n c
1
GFP T2At mCherry^
Figure 4-2: Assaying HR after TALEN activity
HR mediated repair of a DSB in a non-functional GFP (^saGFP) uses a donor 
plasmid carrying a truncation m utant of GFP (GFF^^(=), leading to GFP 
expression. Adapted from Certo et al. (2011).
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4-5 Conclusions
Increasing evidence places the Id family of proteins as central regulators of stem 
cell function. The present work initially examined the maintenance of mES 
pluripotency by M l. A model proposed by Romero (2009) in which M l inhibits 
Zebl (a putative repressor of Nanog) is not supported by the present data, as 
Zebl protein levels appear to be very similar in WT and IdV^' mES cells. Zeb2 
mRNA is elevated >20-fold in mES cells, though it is unclear whether Zeb2 
protein is elevated in these cells.
The role of the Id family in acquired pluripotency has also been examined. 
Ablation of Id l  or Id3  greatly reduces the efficiency of reprogramming MEFs in 
the absence of feeder cells. However, with feeder cells, no difference in 
reprogramming efficiency was observed between WT and Idl'^' MEFs. 
Interestingly, as MEFs are reprogrammed towards pluripotency. M l and M3 
transcripts levels decrease and are lowest in established pluripotent lines.
Measuring changes in M l protein and transcript during the in vitro senescence 
of primary MEFs led to the hypothesis that M l is post-transcriptionally 
repressed. Using a series of reporter constructs, a small, highly conserved region 
of the M l 3’ UTR appears to be required to mediate repression. Despite the 
presence of a conserved miR-381 / miR-539-3p binding site in this region, 
attempts to modulate the activity of these two miRNAs does not appear to alter 
repression by the M l 3’ UTR in a reporter or M l protein levels. Functional tools 
designed to mutate this region have been generated and future work will focus 
on the derivation of m utant cell lines and examine the consequence of ablating 
this repressive mechanism.
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Figure A-1: Map of pCAG2LMKOSiO
Regions encoding Myc, Klf4, Oct4 and Sox2 are separated by 2A self-cleaving 
peptide sequences (small orange squares). An 1RES element permits expression 
of mOrange. The plasmid can be linearised using the unique Pvul site, located 
in the ampicillin resistance gene (AmpR). Constructed by Kaji et al. (2009).
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pLM-fSV2A
11.660 kb
Figure A-2: Map of pLM-fSV2A
Regions encoding 0CT4, KLF4, MYC and 80X2 are separated by 2A self­
cleaving peptide sequences (small orange squares). Constructed by Papapetrou 
et al. (2011).
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Figure A-3: Map of pBabe-Flag
P ro te in  coding sequences can  be cloned u s in g  th e  u n iq u e  Xhol, EcoRI a n d  
B am H I sites , w hich im m ed ia te ly  p recede th e  FLAG sequence (sm all o range  
square). R ela tive  location of th e  am pic illin  re s is ta n c e  gene (AmpR)  an d  
purom ycin  re s is ta n c e  genes (PuroR)  a re  also show n. C o n stru c ted  by L. B everly.
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Figure A-4: Map of pBabe-Zeb 1-Flag
P ro te in  coding sequence of m ouse Z eb l w as cloned u s in g  th e  EcoRI / X hol s ite s  
in  pB abe-F lag .
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Figure A-5: Map of pBabe-Zeb2-Flag
P ro te in  coding sequence of m ouse Zeb2 w as cloned u s in g  th e  EcoRI / X hol s ite s  
in  pB abe-F lag  a n d  in tro d u ced  com patib le  M fel / S a il s ite s  on Zeb2. E ndogenous 
EcoRI an d  X hol s ite s  a re  show n.
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F igure  A-6: Map of Bd.LV
3’ UTR sequences can be cloned immediately downstream of GFP using the 
unique Nhel and Agel sites. Produced by Brian Brown and Luigi Naldini.
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